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Abstract
Despite the fact that C. jejuni is a leading cause of bacterial enteritis in Canada,
there is no diagnostic assay available to identify high-risk strains. This represents a
significant challenge towards the prevention and control of campylobacteriosis.
Additionally, molecular epidemiological studies have shown that not all C. jejuni strains
or lineages appear to pose an equal risk to human health, and the factors underlying this
subtype-dependent pathogenesis are not understood. A Genome-Wide Association Study
was conducted to identify genetic markers associated with C. jejuni strains linked to
human illness. These markers were implemented in a molecular-based risk assessment
assay, and used to screen isolates collected as part of a national microbial survey of
Canadian poultry products. This study suggests that strains with a diverse metabolic
toolkit may pose an elevated risk by virtue of their ability to overcome ecological barriers
that might otherwise mitigate exposure to humans.
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1Chapter 1
1 Literature review
1.1 The genus Campylobacter: then and now
The earliest description of Campylobacter may have been penned by Theodor
Escherich in his1886 post-
(Shulman et al., 2007) where he
described vibrio-like organisms in the stools of infants with diarrhea. However, it would
be another 20 years before it was finally isolated by researchers from the United
Kingdom. The British government commissioned a study in 1905 to investigate the cause
of a significant number of epizootic abortions in cattle and sheep. The investigation fell
to John McFadyean, the Dean and Professor of Pathology and Bacteriology at the Royal
Veterinary College in London, and his colleague, Stewart Stockman, the Chief Veterinary
Officer to the Board of Agriculture and Fisheries (Skirrow, 2006). It was early February
in 1906 when McFadyean and Stockman isolated a pure culture of an unknown,
shaped organism from the uterine mucous of a pregnant sheep. They described an
organism that was spiral shaped, motile, and grew after 1-4 days at temperatures between
35-37°C. Growth was absent or poor on the surface of agar under aerobic conditions, but
was favoured in a rarefied atmosphere. McFadyean and Stockman also described the
appearance of s in culture and pathogenic material, which today,
along with their other observations, are well-recognised features of the Campylobacter
species (Blaser, 1997; McFadyean & Stockman, 1913; Ng et al., 1985).
2Several years later in the United States, Theobald Smith and Marian Taylor isolated
an organism from aborting cattle that was identical to the organism isolated in the United
Kingdom. They called it Vibrio fetus (Smith & Taylor, 1919) and the disease became
known as abortion, which was of major economic concern at the time
(Skirrow, 2006). Over the next several decades, researchers identified several other
species including V. jejuni (Jones et al., 1931), V. sputorum subsp. sputorum
(Prévot, 1940), V. coli (Doyle, 1944), V. sputorum subsp. bubulus (Florent, 1953), and V.
fetus subsp. venerealis and V. fetus subsp. intestinalis (Florent, 1959). However, in 1963,
French researchers, Véron and Chatelain, determined that Vibrio fetus required
reclassification as its own genus (Sebald & Veron, 1963). Their experiments assessing
the phenotypic characteristics and the G+C content of the DNA showed that Vibrio fetus
was very different from Vibrio cholerae and related Vibrio species. In fact, the only
characteristic they had in co shape of their cells, and thus, the
genus Campylobacter, was proposed (Veron & Chatelain,
1973). The first documented cases where Campylobacter was linked to diarrhea in
humans was in 1957 (King, 1957); however, when new
techniques were developed for the isolation of Campylobacter from stool that led to its
widespread recognition as a human pathogen causing gastrointestinal illness (Blaser et al.,
1979).
Belonging to the epsilon class of proteobacteria and the order Campylobacteriales,
the genus Campylobacter is now known to comprise 26 species, of which 22 have been
associated with human illness (Fitzgerald, 2015). Campylobacter species are gram-
negative, non-spore forming bacilli that typically possess a spiral, or curved shape
between 0.2 to 0.8 µm wide and 0.5 to 5 µm long. They are motile via a single,
3unsheathed uni- or bipolar flagellum, which propels the organism with a characteristic
corkscrew-like motion (Blaser, 1997).
In the laboratory, campylobacters are seen as fragile: sensitive to aerobic, acidic and
highly osmotic environments, desiccation and temperature extremes. They are
microaeophilic and grow best in atmospheres comprising 3-15% oxygen and 2-10%
carbon dioxide. Campylobacters live in the digestive tracts of many different wild and
domesticated animal species, which act as reservoirs for human disease (Blaser, 1997).
They are found regularly in animals used for food production including cattle, sheep,
pigs, and poultry, have been isolated from household pets including cats, dogs, and birds,
and despite their fastidious nature in the laboratory, campylobacters are isolated readily
outside the host from environmental waters and soils (Blaser, 1997).
Change in the morphological structure of campylobacters from spiral to coccoid in
shape has been observed in old cultures and under unfavourable conditions. This
is thought to enhance survivability outside of the host
where growth conditions are poor (Cappelier & Federighi, 1998; Thomas, C. et al., 2002).
Recent work has demonstrated that such cells can still express virulence genes and adhere
to epithelial cells (Chaisowwong et al., 2012), substantiating concerns that VBNC cells,
which are not always detectable by culture, may remain infectious and pose a threat to
human health. Campylobacters have also been shown to form mono-culture biofilms or
integrate into pre-existing biofilms comprising other bacteria, which renders them much
more resistant to environmental extremes as well as disinfectants, and may be a
contributing factor in their persistence and spread (Magajna & Schraft, 2015).
A thermotolerant subset of Campylobacter species that are capable of growth
between 30°C to 42°C includes C. lari, C. upseliensis, C. hyointestinalis, C. lanienae, C.
4sputorum, C. jejuni and C. coli. Campylobacter jejuni is delineated into two subspecies:
jejuni and doylei. The pathogenic role of C. jejuni subspecies doylei is unknown, and is
infrequently isolated. It is primarily isolated from human clinical samples associated with
patients suffering from bacteremia, especially infants. It has yet to be isolated from an
animal host, grows poorly at 42°C, and does not reduce nitrate (Parker et al., 2007).
Thus, hereafter, C. jejuni will refer to C. jejuni subspecies jejuni exclusively. The subset
of thermotolerant species are most commonly associated with human infection, but an
overwhelming majority of cases (>95%) are attributed to C. jejuni (80-94%) and C. coli
(2-15%) based on data from developed countries that use selective media culture for
identification (Baylis et al., 2000; Blaser, 1997; Park, 2002). However, because of
technical limitations of the current culture and phenotypic methods commonly used for
detection, isolation, and typing of Campylobacter, the aforementioned figures likely
result in under reporting of non-jejuni/coli species in clinical specimens, and therefore,
the pathogenic potential of other Campylobacter species may be underestimated
(Fratamico et al., 2008; Moore & Goldsmith, 2001).
1.2 Campylobacteriosis: A human disease
1.2.1 Overview of the disease
Infection with Campylobacter can result in a variety of diseases including acute
enteritis, as well as extraintestinal infections such as bacteremia, abscess, meningitis, and
other more severe post-infection complications including reactive arthritis, Guillain-Barré
Syndrome (GBS), Miller Fisher Syndrome (MFS) and Irritable Bowel Syndrome (IBS)
(Allos & Blaser, 1995; Blaser, 1997; Bremell et al., 1991; Garcia-Rodríguez et al., 2006;
5Lecuit et al., 2004; Pope et al., 2007). In fact, case studies have demonstrated that C.
jejuni is the leading bacterial antecedent of GBS having been found in 25-50% of
patients, and there is evidence showing that some strains of C. jejuni produce ganglioside
mimics found in neural tissues that are recognised by antibodies in the sera of afflicted
patients (Willison et al., 2016). Typically, campylobacteriosis is hallmarked by severe
abdominal pain, bloody diarrhoea, and sometimes fever, nausea and vomiting (Blaser,
1997). The symptoms of the disease manifest themselves 12-24 hours after infection, and
are most severe for 24-48 hours, while dissipating over the course of a week. The disease
is typically self-limiting lasting 5-7 days, though a small percentage of patients relapse
after their initial illness. Appreciable numbers of bacteria can persist in faeces for 2-3
weeks after the initial infection (Blaser, 1997), but human to human transmission is rare
(Musher & Musher, 2004). Long-term carriage of Campylobacter is often only observed
in patients with immune deficiencies such as hypogammaglobulinemia and AIDS.
Extraintestinal infections are more commonly observed in individuals who are
immunocompromised, elderly or pregnant, and typically present as bacteremia with or
without diarrheal illness. In most cases, the disease is self-managed by the patient with
water and electrolytes. However, in cases where the patient is immunocompromised, or
symptoms are especially severe, antibiotics such as erythromycin, tetracyclines or
fluoroquinolones may be administered (Kirkpatrick & Tribble, 2011).
Investigations involving the experimental infection of human volunteers with
Campylobacter have shown that the infectious dose can be as low as 500 cells (Black et
al., 1988). These data are consistent with the observation that most recorded
Campylobacter outbreaks result from the consumption of contaminated water or
unpasteurised milk products since these matrices can act to lower the infectious dose
6through buffering mechanisms, and rapid wash-through of stomach contents (Blaser et al.,
1980; Murphy et al., 2006). However, the clinical consequences of an infection can vary
in part based on the virulence of the infecting strain, the infectious dose, and the
susceptibility of the patient (Black et al., 1988).
1.3 Prevalence and ecology
1.3.1 Overall prevalence
Campylobacter is considered to be the leading cause of bacterial foodborne
gastroenteritis in the world (Batz et al., 2012; Galanis, 2007; WHO, 2013) and a
significant cause of child morbidity and mortality in developing nations (Lanata et al.,
2013). It is estimated to be responsible for as much as 14% of all diarrheal disease,
translating to more than 400 million cases of campylobacteriosis annually (Duong &
Konkel, 2009). In countries with active surveillance for this pathogen, the incidence of
campylobacteriosis has risen annually (Park, 2002). The organism is ubiquitous in nature
having been isolated from a broad range of wild animals and birds, domesticated animals
including food animals and companion animals, as well as from environmental sources
including waters and soils (Blaser, 1997).
1.3.2 Human incidence
In Canada, Campylobacter is the most common cause of bacterial gastroenteritis
with annual incidence rates approaching 33 cases per 100,000 individuals (PHAC,
2015a). However, statistical models that account for unreported and undiagnosed cases
suggest this rate could be as high as 447 cases per 100,000 individuals (Thomas, M. et al.,
72013). The highest rates are observed in children under 5 years of age and in young
adults, particularly males, between the ages of 20-29 (PHAC, 2009). Campylobacter is
also the most common cause of among Canadians travelling to
developing nations (PHAC, 2015b). These trends are typical of what has been reported in
other industrialised nations (Blaser, 1997). The economic burden of campylobacteriosis
in Canada has not been calculated, however, acute gastrointestinal illness is estimated to
cost $115 per capita (Majowicz et al., 2006). In the United States, it is estimated that a
case of campylobacteriosis costs approximately $2,283 totalling between $903 million to
$4.9 billion annually, and was second only to norovirus for quality-adjusted life years lost
(Batz et al., 2012; Hoffmann et al., 2015).
In developing nations, Campylobacter is endemic, but disease is generally confined
to young children. It is thought that frequent and multiple exposures to a wide variety of
strains early in life (i.e. via contaminated drinking water and close contact with farm
animals) may result in protective immunity against subsequent infections and/or disease
(Blaser, 1997; Calva et al., 1988; Rao et al., 2001), and could also reflect why
asymptomatic Campylobacter infections are common in these regions (Havelaar et al.,
2009). However, there is emerging evidence suggesting that both symptomatic and
asymptomatic Campylobacter infections in children can result in growth faltering, which
has been associated with a number of long-term negative effects including poorer
cognitive development, lower adult work capacity and income, and poorer pregnancy
outcomes (Lee et al., 2013).
81.3.3 Prevalence in agriculture animals
1.3.3.1 Poultry
Campylobacter is a commensal organism in poultry (Dhillon et al., 2006). It can
colonise to high concentrations in the lower gastrointestinal tract, and can be found
naturally within the tissues of lymphoid organs, liver and gallbladder (Cox et al., 2006).
The most recent national poultry baseline survey in Canada found that 24% of flocks
were colonised with Campylobacter, and a similar survey in the European Union found
that 71% of flocks were colonised with Campylobacter (CFIA, 2016; EFSA, 2010). Once
Campylobacter has been detected in a flock, it is recovered in very high numbers from
most of the remaining birds within a few days, as well as from the surrounding
environment (Shreeve et al., 2000). Colonised flocks typically remain positive until
slaughter, where high levels of Campylobacter in the intestinal content can contaminate
meat during processing (Oosterom et al., 1983). Retail poultry products are often
Campylobacter-positive in Canada and in other industrialised nations, with prevalence
ranging from 30% - 93% and is considered to be the leading source of exposure to human
campylobacteriosis (CFIA, 2016; EFSA, 2010; PHAC, 2015b; Pointon et al., 2008).
1.3.3.2 Cattle
Cattle have been shown to be reservoirs for a number of thermophilic
Campylobacter species including C. jejuni, C. coli, C. hyointestinalis, C. fetus and C.
lanienae (Busato et al., 1999; Inglis et al., 2003; Stanley & Jones, 2003). Numerous
investigations probing the prevalence of campylobacters in cattle populations have
yielded estimated carriage rates ranging between 0.8% - 100% , depending on factors
9such as age, cattle type, herd size, season, and whether the herd is on pasture, or in a
feedlot (Garcia et al., 1985; Giacoboni et al., 2013; Hoar et al., 2001; Humphrey &
Beckett, 1987; Inglis et al., 2004; Minihan et al., 2004; Nielsen, 2002; Stanley et al.,
1998a; Stanley & Jones, 2003; Wesley et al., 2000). Studies have shown that a high
percentage of cattle in feedlots chronically shed high numbers of campylobacter cells in
their faeces (Besser, T. et al., 2005; Minihan et al., 2004). Campylobacters excreted in
cattle faeces sent to compost can persist for up to 10 months (Inglis et al., 2010), which is
in contrast to the common belief that campylobacters fare poorly in solid manure once
excreted (Gilpin et al., 2009; Hoar et al., 1999; Nicholson et al., 2005; Sinton et al., 2007;
Xu et al., 2009), and could be a persistent source of contamination on the farm and
surrounding environment. While the prevalence of Campylobacter on cattle carcasses
can be as high as 89% at time of slaughter, with the exception of offal, the prevalence of
Campylobacter in retail products is negligible and not generally considered to be a risk
for human campylobacteriosis (Bolton et al., 1985; Little & de Louvois, 1998; Stanley &
Jones, 2003). In Canada, the prevalence of campylobacters in ground beef at retail is less
than 1%, and data are no longer available after 2010 (PHAC, 2014; PHAC, 2015b).
1.3.3.3 Swine
Swine have been established as a reservoir for Campylobacter species including
jejuni and coli, although, in contrast with poultry and cattle, C. coli is more prevalent than
C. jejuni (Horrocks et al., 2009). Between 2011 and 2012 in Canada, Campylobacter was
recovered from 85% of pooled-manure samples on swine farms, with 95% of isolates
speciated as C. coli (PHAC, 2015a). Other studies in Canada have indicated that
Campylobacter is highly prevalent on swine farms where between 40-100% tested
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positive for the organism, with carriage rates in samples (e.g. faecal samples or caecal
contents) between 30-100% and C. coli was the dominant species isolated (Farzan et al.,
2010; Guevremont et al., 2004; Munroe et al., 1983; Varela et al., 2007). The Canadian
data presented here are similar to those from other industrialised nations (Alter et al.,
2005; Thakur et al., 2010). Quantification of caecal content at the abattoir indicated that
pigs continue to harbour high levels of Campylobacter until slaughter with an average of
104 CFU/g faeces (Weijtens et al., 1997), and thus, can be a source of contamination
during processing of pork products. However, while the prevalence of campylobacters on
swine carcasses during various stages of processing ranged between 9-76%, it was not
isolated after the chilling stage (Bracewell et al., 1985; Oosterom et al., 1985; Pearce et
al., 2003). In Canada campylobacters are rarely isolated from pork products at retail, and
are not generally considered to be a risk for human campylobacteriosis (PHAC, 2015a).
1.3.4 Prevalence in companion animals
It is well-established that dogs are carriers of many different thermophilic
Campylobacter species including predominantly C. upsaliensis, but also, C. jejuni, C.
coli, C. helveticus, C. lari and others (Engvall et al., 2003; Hald et al., 2004; Koene et al.,
2004; Rossi et al., 2008; Tsai et al., 2007). Dogs can naturally carry multiple
Campylobacter species simultaneously; however, the species richness can be elevated in
diarrheic animals (Chaban et al., 2010), and illness may be associated with C. jejuni,
especially in young and immunocompromised dogs (Burnens et al., 1992; Fox et al.,
1983). In Canada, studies investigating the prevalence of Campylobacter species in pet
dogs have demonstrated carriage rates between 22-58% in healthy dogs and as high as
97% in diarrheic dogs (Chaban et al., 2010; Leonard et al., 2011), which are similar to
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data from other countries, where prevalence rates ranged between 2-100% (Hald et al.,
2004; Leahy et al., 2016; Mohan et al., 2017; Tsai et al., 2007).
Cats are also known carriers of several thermophilic Campylobacter species
including predominantly C. helveticus, but also C. jejuni, C. coli and C. upsaliensis, and
can also be diversely colonised with multiple species (Rossi et al., 2008; Shen et al.,
2001; Wieland et al., 2005). While data from Canada is unavailable, the prevalence of
campylobacters in cats reported by other industrialised nations ranged between 28-75%
(Acke et al., 2009; Shen et al., 2001; Wieland et al., 2005), and with the exception of one
study, which found C. jejuni to be more prevalent in diarrheic and young cats (Acke et al.,
2009), there is no apparent association between a particular species of Campylobacter and
gastroenteritis (Burnens et al., 1992).
Although the prevalence of C. jejuni and C. coli are relatively low in dogs and cats,
other more prevalent species, especially C. upsaliensis, have been associated with disease
in humans (Logan et al., 2000). And because of the exceptionally close contact shared
between humans and companion animals (including their faeces), pets are considered to
be a risk factor for contracting campylobacteriosis (Horrocks et al., 2009).
1.3.5 Prevalence in wild birds
Thermophilic campylobacters, especially C. jejuni and to a lesser extent, C. coli and
C. lari, are considered to be widely distributed amongst wild bird species, with
prevalence ranging from 0-90% (Colles et al., 2008; Hald et al., 2016; Keller et al., 2011;
Van Dyke et al., 2010). A 2017 study from South Korea assessed the prevalence of
campylobacters in 71 different species and demonstrated an overall isolation rate of
15.3%, although the prevalence varied between different avian families (Kwon et al.,
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2017). In Canada, studies investigating the prevalence of campylobacters in wild birds
have focused largely on waterfowl and seabird species with isolation rates ranging
between 0-29% (Dobbin et al., 2005; Hoar et al., 2007; Inglis et al., 2007; Quessy &
Messier, 1992; Van Dyke et al., 2010). The variability of Campylobacter prevalence
observed among different species or families of birds is thought to be partially linked to
foraging strategies; for example, gulls and crows found foraging in landfills, and species
that forage off the ground within close proximity to agricultural operations, were found to
have a higher prevalence of Campylobacter (Hald et al., 2016; Waldenstrom et al., 2002).
Other factors such as social behaviours (e.g. communal roosting) and habitat-use have
been shown to contribute to both intra-and inter-species spread of campylobacters (Taff et
al., 2016). Wild birds, therefore, may act as a reservoir and conduit for the transmission
of campylobacters amongst themselves, other wild and domesticated animals, as well as
humans, via contamination of the environment, animal feed supplies and human food
sources (Weis et al., 2016). For example, in the United States, a recent outbreak of
campylobacteriosis in humans was clinically linked to raw peas contaminated with wild
bird faeces (Gardner et al., 2011; Kwan et al., 2014).
1.3.6 Prevalence in wild animals
A variety of thermophilic Campylobacter species have been isolated from various
terrestrial and aquatic mammals including hedgehogs, various mouse, vole, rat and shrew
species, moles, squirrels, hares, badgers, skunks, racoons, foxes, wild boars, deer, horses,
buffalo, non-human primates, and seals, as well as from reptiles including a tortoise and
various species of lizards with isolation rates ranging between 0-67% (Baily et al., 2015;
Benejat et al., 2014; Gilbert et al., 2014; Jokinen et al., 2011; Kakoyiannis et al., 1988;
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Koga et al., 2015; Mutschall et al., 2015; Navarro-Gonzalez et al., 2014; Petersen et al.,
2001; Rainwater et al., 2017; Viswanathan et al., 2017; Whiley et al., 2016). Although it
is generally accepted that campylobacters isolated from wildlife are commensal in nature,
some species have been associated with disease in specific hosts (Baily et al., 2015;
Benejat et al., 2014; Gilbert et al., 2014). The role of wildlife as possible reservoirs and
vectors of campylobacters is not well understood; several recent molecular-based
epidemiological investigations have indicated that wildlife tend to carry different
Campylobacter species as compared to wild birds, domestic animals and humans, and if
species overlap was observed, isolates were genetically distinct (Gilbert et al., 2014;
Navarro-Gonzalez et al., 2014; Petersen et al., 2001; Viswanathan et al., 2017).
However, a strain of C. jejuni isolated from raccoons at a wildlife rehabilitation centre
was implicated as the causative agent in an outbreak of human campylobacteriosis, and
another study investigating the prevalence of C. jejuni in wild grey seal pups determined
that isolates from these animals were genetically similar to human clinical isolates (Baily
et al., 2015; Saunders et al., 2017). Thus, while campylobacters have been isolated from
a broad range of wild animals, their importance in the epidemiology of human
campylobacteriosis may be restricted to species that regularly interface with agricultural
operations and/or human population centres, which can result in their exposure to and
spread of campylobacters atypical of the wild environment, but relevant to human health.
1.3.7 Prevalence in environmental waters
Thermophilic campylobacters have been isolated from all types of environmental
water sources, including surface waters (e.g. ponds, lakes and rivers), groundwater,
wastewater effluent and seawater, and have been implicated as the cause of waterborne
14
outbreaks in Canada and around the world (Clark et al., 2003; Khan et al., 2014; Pitkänen,
2013; Schuster et al., 2005). Sources of contamination include run-off from farms,
abattoir effluent and slurries, human sewage, and faecal contamination from domestic
animals and wildlife (Khan et al., 2014). Watersheds serve many needs, including
drinking, irrigation and recreation and support both livestock and wildlife. Surface
waters, particularly those near major agricultural operations, have been well-studied in
Canada, where thermophilic campylobacters, including C. jejuni and C. coli, are
frequently detected with prevalences from 0-100% depending on the season, proximity to
and type of agricultural activities (Huang et al., 2015; Jokinen et al., 2010; Jokinen et al.,
2011; Khan et al., 2014). Furthermore, studies have shown isolates from water are
genetically similar to those from domestic and wild animals that inhabit the same
geographical region (Jokinen et al., 2011). These data suggest that water is an important
source of Campylobacter and an efficient vehicle for transmission between wildlife,
domestic animals, and humans.
As described earlier, campylobacters -
integrate into biofilms when conditions are not favorable (Cappelier
& Federighi, 1998). Additionally, there is evidence that microbial eukaryotes may act as
a nonvertebrate reservoir of campylobacters in the environment (Kaakoush et al., 2015).
These mechanisms may act to enhance the persistence and transmissibility of
campylobacters in environmental waters.
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1.4 Epidemiology of Campylobacter infections
1.4.1 The endemic nature of Campylobacter
The vast majority of cases of campylobacteriosis, greater than 95%, are said to
occur as sporadic, or endemic infections (Blaser, 1997). In Canada, between 2000 and
2004, 99.8% of all confirmed cases were classified as sporadic, and only 177 cases were
attributed to outbreaks (PHAC, 2009). Epidemiological investigations using case control
studies have indicated that contact with, or consumption of improperly cooked poultry
products account for 50-70% of all endemic cases (Blaser, 1997; Friedman et al., 2004).
The consumption of unpasteurised milk and milk products (Hopkins et al., 1984),
consumption of untreated, contaminated water (Fullerton et al., 2007), contact with
livestock and pets (Friedman et al., 2004; Potter et al., 2003), occupational exposure in
abattoirs (Cawthraw et al., 2000; Eberhart-Phillips et al., 1997), contact with infected
individuals, and travel in developing countries (Blaser, 1997) are other dominant routes of
infection.
1.4.2 Campylobacter outbreaks
Despite its relatively low infectious dose and status as an enteric pathogen,
outbreaks of campylobacteriosis are rare. It is possible that the fragile nature of
Campylobacter¸ such as sensitivity to atmospheric oxygen, heat, ultraviolet radiation,
desiccation, and that it does not readily multiply at room temperature (Baylis et al., 2000;
Blaser et al., 1980) precludes it from large-scale outbreaks related to solid foods (Franco,
1988). This is consistent with the fact that most documented outbreaks are a result of the
consumption of unpasteurised milk and untreated and/or contaminated water, although
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outbreaks due to the consumption of contaminated foods, especially poultry, have been
reported (Blaser, 1997). More recently, several Campylobacter outbreaks have been
attributed to contact with animals, or their faeces, including an outbreak caused by faecal
contamination of peas by wild birds, contact with raccoons at a wildlife rehabilitation
centre, and contact with puppies at a chain of pet stores (CDC, 2018; Gardner et al., 2011;
Kwan et al., 2014; Saunders et al., 2017). In Canada, of 138 documented outbreaks
between 1978 and 2005, a majority were associated with poultry and dairy products,
although Campylobacter has been associated with serious waterborne outbreaks including
in Walkerton, Ontario in 2000 (Clark et al., 2003).
In addition to the considerable underreporting of Campylobacter, the lack of, or
inconsistent application of surveillance programs and subtyping methodologies may limit
the detection of outbreaks, especially if they are small or widely dispersed. Furthermore,
the ubiquitous nature of Campylobacter, its low infectious dose, the ease at which cross-
contamination may occur, the possibility of contamination by multiple subtypes, and the
relatively long incubation period may act to obfuscate the identification of a discrete
source of contamination that results in a cluster of related illnesses (Ethelberg et al., 2004;
PHAC, 2009; The Campylobacter Sentinel Surveillance Scheme Collaborators, 2003).
1.4.3. Seasonal variation of Campylobacter infections
The number of Campylobacter infections, particularly in countries with temperate
climates, including Canada, follows a well-defined seasonal pattern that is characterised
by a dramatic increase in the spring, followed by a peak in the summer, and a gradual
decline in the fall and winter months (Kapperud & Aasen, 1992; Kovats et al., 2005;
Miller et al., 2004; Nylen et al., 2002; PHAC, 2009; Skirrow, 1987). Some countries
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observed a peak, or multiple peaks in the summer months, which are believed to be a
result of travel related infections (Ekdahl & Andersson, 2004; Kovats et al., 2005).
Given the complexity of the epidemiology of Campylobacter, it is uncertain what
drives this peculiar phenomenon. However, it is possible that the seasonal changes in
environmental conditions may alter the dynamics of transmission of Campylobacter by
changing the behaviour of wild animals and migrating birds, known reservoirs of the
pathogen, and the recreational activities of humans, resulting in increased exposure and
subsequent illness (Lacey, 1993; Olson et al., 2008; Southern et al., 1990). The warmer
weather also represents a marked increase in agricultural activity of both production
animals and produce. Interestingly, the carriage rates are highest in the summer for
poultry tested at various stages of production including on the farm, at slaughter, and at
retail, with a similar seasonal peak in the percentage of infected broiler flocks occurring
just prior to that of human infections (Meldrum et al., 2005; Patrick et al., 2004; Wilson,
I., 2002). Other studies showed that seasonal peaks in isolates from lambs, cattle and
sewage occurred one to two months prior to the peak of human infections, which along
with poultry, may be associated with the seasonal cycle of campylobacteriosis in humans
(Kovats et al., 2005; Stanley et al., 1998a; Stanley et al., 1998b; Wallace et al., 1997).
1.4.4 Transmission
Elucidating the transmission pathways of Campylobacter is critical towards
developing mitigation strategies to reduce human campylobacteriosis. However, this is
proving a daunting task given the widespread prevalence amongst wild and domesticated
animal species and in the environment (Blaser, 1997). Generally speaking, transmission
occurs via the consumption of contaminated food, water and contact with infected or
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reservoir hosts and their faeces (Humphrey et al., 2007). With recent advancements in
molecular typing strategies for Campylobacter, it has become apparent that the
transmission of pathogen to human can vary based on regional factors, and that there are
other important points of Campylobacter contamination
continuum (Hannon et al., 2009; Taboada et al., 2015). For example, recently described
outbreaks associated with campylobacters from wildlife, wild birds and pets highlight
potentially underrepresented sources of human infection, and necessitates further
surveillance of species that regularly interface with humans, and of environmental sources
at sites where this occurs (CDC, 2018; Kwan et al., 2014; Saunders et al., 2017).
While poultry has long been considered a predominant source of human
campylobacteriosis (Blaser, 1997), recent molecular epidemiological studies in Canada
have indicated there is a marked difference in the attribution of human Campylobacter
cases in rural versus urban environments, where human isolates are more closely related
to those from cattle versus those from poultry, respectively (Hannon et al., 2009; Taboada
et al., 2015). Moreover, subtyping of isolates collected as part of a recent Canadian
initiative to establish a national baseline estimate of the prevalence of campylobacters in
broiler chickens and chicken products (CFIA, 2016) showed that while poultry remains a
significant reservoir for Campylobacter in Canada, subtypes exclusive to chicken account
for only a small percentage of clinical cases, and a majority of clinical cases arise from
subtypes of mixed-host origin (presented in Chapter 3).
Thus, in order for future mitigation strategies to be effective, it is important to
consider regional influences on Campylobacter ecology, and to continue to invest in
broader molecular epidemiological studies and surveillance programs that not only
investigate the ecology of these clinically important mixed-host subtypes observed in the
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agriculture domain, but to also establish the transmission dynamics between animals,
humans and the environment -to- continuum.
1.5 Subtyping of Campylobacter jejuni
1.5.1 A rationale for subtyping
The fundamental purpose of subtyping is to identify distinct lineages or sub-
lineages that comprise the population structure of a bacterium by assaying phenotypic or
genotypic markers. However, the true utility of subtyping is as a framework for which
metadata, such as important phenotypic traits or epidemiological features, can be overlaid
to identify subtypes of interest. Subtyping is an indispensable component of modern day
epidemiology; it is used for surveillance, outbreak detection and mitigation, and as part of
a more holistic approach to understanding the ecological epidemiology of C. jejuni, which
can be used to develop more efficacious and targeted mitigation strategies (Ahmed et al.,
2012; Taboada et al., 2013).
1.5.2 Phenotypic subtyping methods
The first subtyping methods developed for C. jejuni were designed to differentiate
strains based on phenotypic physical and/or biochemical characteristics (Taboada et
al., 2013). Many phenotypic subtyping schemes were developed including biotyping
(Bolton et al., 1984; Lior, 1984; Skirrow & Benjamin, 1980), serotyping (Lior et al.,
1982; Penner & Hennessy, 1980), phage typing (Grajewski et al., 1985), resistotyping
(Ribeiro et al., 1996), and multilocus enzyme electrophoresis (MEE) (Aeschbacher &
Piffaretti, 1989; Moore et al., 2002). However, with the exception of the serotyping
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schemes, the widespread adoption of these methods was limited; technical aspects
between independently developed biotyping and phage typing schemes, for example,
lacked consistency across the scientific community, which hindered inter-laboratory
comparison of subtyping data. Serotyping and phage typing were labour intensive,
technically demanding and time consuming, while the maintenance and quality control of
antisera and phage panels were expensive (Wassenaar & Newell, 2000). Additionally,
serotyping and phage typing were prone to non-typeable strains and to problems with
cross-reactivity, and although these methods had higher discriminatory power than
biotyping and resistotyping, none had the discriminatory power to consistently reconcile
subtyping data with epidemiological data (Moore & Madden, 2003; On et al., 2008; Sails
et al., 2003). While MEE appeared to be highly discriminatory relative to other
phenotypic methods (Moore et al., 2002), advances in molecular biological techniques led
to the concurrent development and popularisation of genotypic methods.
1.5.3 Genotypic subtyping methods
Genotypic subtyping methods differentiate bacterial strains by interrogating the
organism s DNA for certain genomic features such as different restriction sites, the
presence or absence of genes or other genetic markers, and single nucleotide
polymorphisms (SNPs) (Taboada et al., 2013). In addition to superior discriminatory
power, standardisation, reproducibility and typeability, genotypic subtyping methods can
be used to infer genomic relatedness amongst isolates (Eberle & Kiess, 2012). While a
wide variety of methods have been used to subtype C. jejuni, (reviewed by Eberle &
Kiess, 2012), only a few have been widely used including pulsed field gel electrophoreses
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(PFGE), flaA Short Variable Region (flaA-SVR), multi-locus sequence typing (MLST), as
well as several more recently developed methods based on whole genome analysis.
1.5.3.1 Pulsed-Field Gel Electrophoresis (PFGE)
PFGE is a subtyping method that uses one or more rare-cutting restriction enzymes
to digest intact genomic DNA into a small number of fragments, which are subsequently
electrophoresed in an agarose gel to separate them based on size. The resulting banding
pattern is C. jejuni, the SmaI and KpnI restriction enzymes are
most frequently used. Although banding patterns can be compared directly on gel,
softwares have been developed to facilitate the inter-laboratory comparison of large
numbers of isolates electronically, and to correct for minor variations in PFGE patterns
that can occur between gels and laboratories (On et al., 2008).
While PFGE is regarded as being highly discriminatory, it has failed, in some
instances, to differentiate epidemiologically-defined outbreak strains from sporadic
strains in highly clonal lineages of C. jejuni (Champion et al., 2002). Moreover, genomic
instability, through processes such as genetic recombination, has been shown to alter
PFGE profiles in closely related strains (Hanninen et al., 1999; Wassenaar et al., 1998),
and although standardised methods for Campylobacter have been developed by PulseNet,
PFGE is considered to be too costly and time consuming for surveillance of sporadic
cases of campylobacteriosis (Taboada et al., 2013).
1.5.3.2 Multi-Locus Sequence Typing (MLST)
MLST is a typing strategy that relies upon PCR amplification and subsequent
sequencing of fragments from seven relatively stable housekeeping genes (asp, glnA,
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gltA, glyA, pgm, uncA, and tkt). The sequenced PCR products are assigned an allele
number based on an identical match to an allele in the global PubMLST database
(https://pubmlst.org/campylobacter/), and the combination of the seven allele numbers is
assigned a sequence type (ST) according to the database. Sequence Types that share four
or more of the same alleles are said to be part of the same clonal complex (CC) or lineage
(Dingle et al., 2001; Suerbaum et al., 2001).
Because of its increased discriminatory power, reproducibility, and relative ease to
generate, interpret and share data, MLST has become one of the most extensively used
subtyping methods for C. jejuni, and has led to important insights into its epidemiology,
population structure and evolution (Taboada et al., 2013). Notably, MLST analysis of a
large number of isolates has shown that C. jejuni is very genetically diverse, weakly
clonal in population structure, and both intra- and inter-species recombination is common
(Dingle et al., 2001). Moreover, MLST analysis of isolates from human, animal and
environmental sources has shown that some lineages are widely distributed in both their
geography and ecology, while other lineages appear to be more restricted (Dingle et al.,
2001; French et al., 2005; Manning et al., 2003), which has been useful for source
attribution to clinical cases (Sheppard et al., 2009). However, if an outbreak with a
common ST occurs, MLST may not have sufficient resolution to differentiate outbreak
strains from epidemiologically-unrelated strains, and a secondary typing scheme may be
required to provide additional discrimination (Sails et al., 2003).
1.5.3.3 Microarray-based comparative genomic hybridisation (mCGH)
Completion of the genomic sequence of C. jejuni NCTC 11168 in 2000 paved the
way for comparative genomics analyses by providing the nucleotide gene sequences
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necessary to generate whole-genome DNA microarrays (Parkhill et al., 2000).
Microarray-based Comparative Genomic Hybridisation (mCGH) is a technique that
compares the presence or absence of thousands of genes in a single experiment based on
the co-hybridisation of differentially-labelled tester and reference strains (Taboada et al.,
2013).
After a series of comparative genomics analyses came available, it became clear
that C. jejuni exhibited extensive genomic diversity, including differential carriage of
accessory genes not conserved across the entire species. This led to the suggestion its
evolution is driven by recombination, with the exchange of genetic material influencing
its ecology and pathogenesis (Champion et al., 2005; Dorrell et al., 2001; Leonard et al.,
2003; Pearson et al., 2003; Taboada et al., 2004). In comparison to other subtyping
methods, mCGH was found to be highly discriminatory, capable of differentiating
between strains with identical genotypes consistent with differences in their epidemiology
(Carrillo et al., 2012; Gripp et al., 2011; Taboada et al., 2008). Although technical
limitations (i.e. low throughout and high cost) precluded the deployment of mCGH as a
tool for molecular subtyping, it led to the development of comparative genomics-
informed typing methods based on assaying differences in gene content (Taboada et al.,
2013).
1.5.3.4 Comparative Genomic Fingerprinting (CGF)
Comparative Genomic Fingerprinting (CGF) is a subtyping method that uses
multiplex PCR to assess the conservation status of 40 genes from the accessory genome
of C. jejuni to reproduce phylogenetic relationships inferred by mCGH analysis.
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Subtyping data are generated through the binarisation of gene conservation profiles,
which can then be compared to infer phylogenetic relationships (Taboada et al., 2012).
Results from a panel comprising more than 400 isolates showed that CGF is highly
concordant with MLST, but with higher discriminatory power (Taboada et al., 2012). In
comparison to MLST, fla-SVR and porA sequence typing, CGF was best suited for the
identification of case clusters (i.e. outbreaks) in a routine surveillance setting, and was the
only method capable of discriminating outbreak isolates from similar, but
epidemiologically unrelated isolates (Clark et al., 2012). In addition to its enhanced
discriminatory power, CGF is rapid, portable, inexpensive, amenable to high throughput
workflows, and as such, has been deployed in Canada as the primary subtyping method
for C. jejuni.
The Canadian Campylobacter Comparative Genomic Fingerprinting Database
(C3GFdb) contains subtyping data for 24,142 Campylobacter isolates representing 4,882
unique subtypes isolated from human (n = 4,697), animal (n = 14,750) and environmental
(n = 4,457) sources from across Canada. The database, in addition to storing subtyping
data, also contains basic epidemiological metadata for each isolate including host source,
date and location. This allows for contextualisation of a given subtype into the broader
epidemiology of C. jejuni in Canada, and provides a snapshot of the characteristics
associated with it. Together, the subtyping and epidemiological data provide an
analytical framework to establish linkages between genotypes and phenotypes of public
health concern. With the enhanced discriminatory power of CGF, the identification of
more precise linkages consistent with local epidemiological trends may be useful for the
development and implementation of cost-effective, targeted mitigation strategies to
minimise human exposure to C. jejuni (Taboada et al., 2015).
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1.5.3.5 Whole genome typing methods
With the advent of rapid and cost-effective next generation sequencing (NGS)
technologies, whole genome sequencing (WGS) is increasingly being deployed for
outbreak analysis and surveillance of bacterial pathogens including Campylobacter
(Llarena et al., 2017). WGS is advantageous because it yields unparalleled genomic
resolution (i.e. the complete genetic sequence), is theoretically backwards compatible
with most molecular subtyping techniques, and simultaneously provides a wealth of
additional information such as the presence of antimicrobial resistance genes and
virulence factors (Besser, J. et al., 2016; Carleton & Gerner-Smidt, 2016).
Predominant analytical approaches for bacterial comparative genomics using WGS
data include whole-genome SNP-based comparisons (either reference based or non-
referenced based), and gene-by gene comparisons such as core genome MLST (cgMLST)
and whole-genome MLST (wgMLST) (Quainoo et al., 2017). The whole-genome SNP-
based approach is highly discriminatory and has proven to be useful for outbreak
analysis; however, a major drawback is the requirement of a highly-related reference
genome to generate SNP-calls, which essentially limits the scope of the analysis to a
particular dataset. On the contrary, for wgMLST, a strain is characterised on a gene-by-
gene basis against a database comprising all known genes or loci (i.e. the pan-genome)
for a bacterial species or genus, which means strains can be compared across datasets and
laboratories. Additionally, the scheme can be extended as novel genes are discovered,
and the analysis yields which can be used as the
basis for preliminary genotypic and phenotypic interpretations.
Although WGS is replacing conventional subtyping tools for outbreak analysis and
routine surveillance of pathogens such as Listeria and Salmonella, existing knowledge
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gaps pertaining to the baseline levels of diversity within and between C. jejuni lineages,
and how the organism evolves during colonisation and infection need to be addressed to
establish robust criteria for case cluster definition during outbreak analyses (Llarena et al.,
2017).
1.6 Genomics of Campylobacter jejuni
1.6.1 Genomic features of C. jejuni
At time of writing, there were 151 completed C. jejuni genomes available on
Genbank (https://www.ncbi.nlm.nih.gov/genome/genomes/149), with thousands of
additional draft genome assemblies available in public repositories including Genbank
and PubMLST (http://pubmlst.org/). The overall genome size of C. jejuni is relatively
small, with an average length of 1.68 megabases (Mb), relatively low G+C content of
30.4%, and is among the densest bacterial genomes with more than 90% of the genome
coding for an average number of 1,633 proteins (Parkhill et al., 2000; Wu et al., 2016).
Although the genomic structure of C. jejuni is largely syntenic, four genomic islands,
termed C. jejuni-Integrated Elements (CJIEs), originally identified in the C. jejuni strain
RM1221, have been shown to be broadly distributed across the species (Fouts et al.,
2005; Parker et al., 2006). CJIE1 has been characterised as a Mu-like phage, while CJIEs
2 and 4 contain phage-related genes including novel endonucleases that disrupt the
natural transformation of infected C. jejuni strains, which may help explain why some
genotypes are relatively stable versus others, and CJIE3 appears to be an integrated
plasmid (Fouts et al., 2005; Gaasbeek et al., 2009; Gaasbeek et al., 2010). Other
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biological effects these genomic islands may mediate in C. jejuni have not been
determined (Clark, 2011).
The C. jejuni genome is hallmarked by the presence of hypervariable sequences
comprising homopolymeric tracts found mostly in regions encoding proteins involved in
the biosynthesis or modification of cell-surface structures including the capsule,
lipooligosaccharide and flagellum. Slipped-strand mispairing in these regions during
replication can result in variation in the length of the homopolymer tract leading to phase
variation during translation, and may play a role in immune avoidance, virulence, host
adaptation or rapid adaptation to environmental changes (Jerome et al., 2011; Parkhill et
al., 2000; Thomas, D. et al., 2014; Young et al., 2007). The frequency of variation within
these sequences is very high, which has led to the suggestion that C. jejuni may behave
similarly to a quasispecies where a population may be made up of many genotypes with
many phenotypes rather than a clonal isolate (Jerome et al., 2011; Parkhill et al., 2000).
Following sequencing of the genome from the C. jejuni strain NCTC 11168, CGH-
based studies demonstrated that the species exhibits extensive genomic diversity (Dorrell
et al., 2001; Leonard et al., 2011; Pearson et al., 2003; Taboada et al., 2004) confirming
earlier observations from MLST-based analyses suggesting that C. jejuni constitutes a
weakly clonal and genetically diverse species (Dingle et al., 2001). A meta-analysis of
the available CGH data revealed that approximately 79% of the C. jejuni genome is
composed of core genes. Core genes are present in all strains, and are typically involved
in vital processes that are essential for survival such as energy
metabolism, cell division, and the synthesis of RNA and DNA (Dorrell et al., 2001;
Pearson et al., 2003; Taboada et al., 2004). Interestingly, many genes that are associated
with virulence also appear to be conserved (Dorrell et al., 2001). The remaining genes,
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termed accessory genes, are generally confined to 16 discrete hypervariable, or plasticity
regions dispersed throughout the C. jejuni genome and have been shown to have
differential carriage across the species (Dorrell et al., 2001; Leonard et al., 2003; Pearson
et al., 2003; Taboada et al., 2004). These genes encode proteins associated with the
biosynthesis of cell surface structures, iron acquisition, respiration, DNA
restriction/modification, sialyation, as well as those with no known function (Dorrell et
al., 2001; Leonard et al., 2003; Pearson et al., 2003; Taboada et al., 2004). Additionally,
C. jejuni is naturally competent (Wang & Taylor, 1990), which has led to the suggestion
that recombination is the primary driver in its evolution. The ability to generate
variability in the accessory genome may represent an additional mechanism through
which C. jejuni can enhance its ecological fitness towards an array of different
environmental conditions and hosts, and may play a role in its pathogenesis (Pearson et
al., 2003; Taboada et al., 2004; Wilson, D. et al., 2009).
1.6.2 Plasmids
Carriage of plasmids occurs in between 19 and 53% of C. jejuni isolates, where a
majority are classified as antibiotic resistance plasmids that are transmissible between
Campylobacter species, but not Escherichia coli (Bacon et al., 2000). Several plasmids
have been sequenced including a representative from a novel subgroup of conjugative
plasmids called mob plasmids, a tetracycline-resistance encoding plasmid called pTet, and
a virulence plasmid called pVir that encodes a Type IV Secretion System (Bacon et al.,
2002; Batchelor et al., 2004; Schmidt-Ott et al., 2005).
The pVir plasmid, originally isolated from the highly pathogenic C. jejuni strain 81-
176, encodes a Type IV Secretion System similar to one in the cag pathogenicity island
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from Helicobacter pylori. Mutation of some of the plasmid-encoded genes resulted in
reduced adherence to and invasion of INT407 enteric epithelial cells in vitro. However,
when the plasmid was transferred to C. jejuni NCTC 11168, no difference in invasiveness
was observed (Bacon et al., 2000). The role of pVir in Campylobacter pathogenesis is
unclear; in one study from Canada, pVir was significantly associated with bloody
diarrhea, while another study from Holland showed no correlation between the two
(Louwen et al., 2006; Tracz et al., 2005). Additionally, pVir is found in only a small
subset of human clinical isolates, which implies it is not essential for C. jejuni
pathogenesis (Louwen et al., 2006; Schmidt-Ott et al., 2005).
1.7 Virulence factors of C. jejuni
C. jejuni is somewhat unique amongst enteric pathogens, as it does not contain any
pathogenicity islands, and encodes relatively few classical virulence factors, most of
which are conserved (Dasti et al., 2009; Dorrell et al., 2001). The molecular mechanisms
underpinning the pathogenesis of C. jejuni have not been completely elucidated, however
virulence factors associated with motility, evasion of the host immune response, host cell
adherence, host cell invasion, protein secretion and alteration of host cell signalling
pathways have been described (Flanagan et al., 2009; Guerry, 2007; Konkel et al., 1999;
Konkel et al., 2001).
1.7.1 Flagella, flagellar-mediated protein secretion and chemotaxis
Flagella and flagellar-motility have long been considered essential for the
pathogenesis of C. jejuni where early work demonstrated that mutants with defective
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flagella were deficient for host colonisation and cellular internalisation (Morooka et al.,
1985; Wassenaar et al., 1991; Yao et al., 1994).
Genes involved in the biogenesis of C. jejuni flagella are tightly regulated by the
FlgS/R two- 28 54 50), which act
in concert to regulate a large number of flagellar-structural and related genes involved in
motility, protein secretion and invasion (Wösten et al., 2004). As with other bacteria, the
flagellar filament is composed of multimers of the protein flagellin, which is highly
immunogenic (Wassenaar & Blaser, 1999). However, in C. jejuni, flagellin is encoded by
two differentially expressed genes (flaA and flaB) that are subject to variation by
mechanisms including recombination and horizontal gene transfer, which can result in
new epitopes and contribute to immune avoidance (Wassenaar et al., 1995).
In addition to motility, it is now understood that the flagellum of C. jejuni also
functions as a Type III Secretion System, which secretes a number of proteins directly
into the host cell, including the Campylobacter invasion antigens (Cia proteins), that help
coordinate its internalisation and aid in its intracellular survival (Neal-McKinney &
Konkel, 2012). C. jejuni flagella may also have a role in the formation of microcolonies
and biofilms, which could promote its survival in the environment (Guerry, 2007;
Haddock et al., 2010).
Chemotaxis is important for the pathogenesis of C. jejuni, where non-chemotactic
mutants failed to colonise the intestine in vivo (Takata et al., 1992). The genome of C.
jejuni possesses orthologues for a number of chemotaxis genes including cheA, cheW,
cheV, cheY, cheR and cheB (Dasti et al., 2009; Parkhill et al., 2000). The protein CheY is
the response regulator responsible for transmitting sensory signals from chemoreceptors
to the flagellar motor, and plays a key role in C. jejuni pathogenesis by directing the
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bacterium towards the mucous lining in the intestine. Mutants lacking, or overexpressing
CheY, showed decreased virulence in vivo; it was postulated this could be due to the
inability to properly chemotact, or in the case of CheY overexpression, affect subsequent
interactions with intestinal epithelial cells (Yao et al., 1997).
1.7.2 Capsule and lipooligosaccharide
C. jejuni produces cell surface structures including capsular polysaccharides
(CPSs), which are organised into a membrane-linked, extracellular capsule surrounding
the bacterial cell and lipooligosaccharides (LOS) (Gourley & Konkel, 2016; Roberts,
1996). The capsule is thought to provide protection against desiccation, and from innate
and acquired immune responses (Keo et al., 2011; Roberts, 1996; Young et al., 2007). C.
jejuni with deficient capsule has shown decreased adherence and invasion in vitro and
decreased fitness in vivo in chicken and ferrets (Bacon et al., 2001; Louwen et al., 2006).
After flagella, LOS play a major role in cellular invasion, where variability in their
structure can modulate the invasiveness of C. jejuni (Guerry et al., 2002; Louwen et al.,
2008). Structural similarity between C. jejuni LOS and human neuronal gangliosides can
trigger the onset of Guillain-Barré Syndrome, a serious autoimmune disorder that causes
paralysis (Allos, 1997; Yuki, 1997). More recent work has demonstrated that C. jejuni
LOS are involved in immune cell recognition, and provide protection from
bacteriophages and antimicrobial peptides (Cullen et al., 2013; de Zoete et al., 2010;
Louwen et al., 2013).
Both the CPS and LOS genes are located within hypervariable regions of the C.
jejuni genome and are subject to recombination (Dorrell et al., 2001). In addition, some
genes contain homopolymeric nucleotide tracts and are thus subject to phase variation
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(Parkhill et al., 2000). This genetic variation results in variability of the CPS and LOS
structures, which may be a strategy for avoidance of the host immune response, and can
influence aspects of a strain s pathogenicity and disease outcome (Bacon et al., 2001;
Guerry et al., 2002).
1.7.3 Adhesion and invasion
Adherence to intestinal epithelial cells is considered to be fundamental to C. jejuni
pathogenesis, and while the genome of C. jejuni does not appear to encode any adherence
organelles such as pili, several adhesins including CadF, FlpA, CapA, PorA, PEB1 and
JlpA have been identified (Larson et al., 2008; Young et al., 2007). Mutants for CadF,
FlpA, CapA, PEB1 and JlpA displayed reduced adherence and invasion in vitro and
reduced or completely abrogated colonisation in vivo (Ashgar et al., 2007; Flanagan et al.,
2009; Jin et al., 2001; Konkel et al., 2010; Monteville & Konkel, 2002; Monteville et al.,
2003; Pei et al., 1998; Ziprin et al., 1999). With the exception of capA, all adhesin-
encoding genes appear to be conserved in C. jejuni (Flanagan et al., 2009).
Invasion is mediated through the binding of CadF and FlpA to the host cell
extracellular protein fibronectin. This interaction, in conjunction with the flagellar-
secreted Campylobacter invasion antigens (Cia), trigger a signal cascade that ultimately
co-opts the cytoskeleton to promote internalisation of C. jejuni and its
subsequent intracellular survival (Eucker & Konkel, 2012; Monteville et al., 2003; Neal-
McKinney & Konkel, 2012). Of the approximately 18 Cia proteins predicted to exist,
only four have been characterised including CiaB, CiaC, CiaD and CiaI, and while their
exact functions have not been determined, both in vitro and in vivo studies suggest they
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are required for maximal invasion and intracellular survival (Buelow et al., 2011;
Christensen et al., 2009; Konkel et al., 1999; Larson et al., 2008; Samuelson et al., 2013).
1.7.4 Toxins
Although early evidence suggested that C. jejuni expresses enterotoxins similar to
the V. cholerae toxin (CT) and the E. coli heat-labile toxin (LT), subsequent studies
yielded contradictory results, and as of yet, the genetic basis for their presence has not
been verified (Dasti et al., 2009; Wassenaar, 1997). To date, the only toxin identified in
the C. jejuni genome is the Cytolethal Distending Toxin (CDT), which causes G2/M cell
cycle arrest and eventual cell death via apoptosis (Parkhill et al., 2000; Whitehouse et al.,
1998). CDT is encoded by three genes including cdtA, cdtB, and cdtC, which when
translated, form a tripartite complex, classified as an AB2 toxin, where the CdtB subunit
C subunits form the binding
subunit (Lara-Tejero & Galán, 2001). The CdtB subunit alone is responsible for its
toxic effects, which when singularly microinjected or transfected into host cells, induced
the same effects as the complete toxin (Lara-Tejero & Galán, 2000). CdtA and CdtC
binding to the host cell and internalisation of the CdtB subunit, which
is then localised to the nucleus where it causes damage to the DNA in a fashion similar to
proteins of the DNase-1 family (Elwell & Dreyfus, 2000; Lara-Tejero & Galán, 2000;
Nishikubo et al., 2003).
Although CDT appears to be conserved across the species, its role and importance
in the pathogenesis of C. jejuni are not clear (Pickett & Whitehouse, 1999). For example,
a study by Mortensen and colleagues demonstrated that the disease outcome of humans
infected by strains with anomalous cdtABC loci that did not express CDT was not
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distinguishable from those with functional CDT (Mortensen et al., 2011). However, it
has been determined that the presence of CDT elicits production of the proinflammatory
cytokine interleukin-8, which results in a localised inflammatory response at the site of
infection, and contributes to the symptoms of campylobacteriosis (Hickey et al., 2000).
1.8 Overview of the thesis
Based on molecular epidemiological studies, it appears that not all C. jejuni strains
or genetic lineages pose an equal risk to human health. For example, the use of MLST
has identified host restricted clonal complexes, and in Canada, the use of CGF has
demonstrated the presence of subtypes that are often associated with human illness and
those that are not (Buchanan et al., 2017; Dingle et al., 2001; French et al., 2005;
Manning et al., 2003). C. jejuni is somewhat unique amongst enteric pathogens; it does
not possess pathogenicity islands, and it expresses relatively few classical virulence
factors (Dasti et al., 2009). Although a number of genes involved in various aspects of its
pathogenesis have been described, they appear to be conserved across the species, and
therefore, the genetic basis for this observed subtype-dependent pathogenesis is not well
understood (Dorrell et al., 2001; Young et al., 2007). From a public health perspective,
this is problematic; unlike other pathogens, such as E. coli for which well-characterised
virulence factors (i.e. shiga toxins), or well-established epidemiological linkages between
certain subtypes (i.e. O157:H7) and human disease are used for risk assessment, no such
tools are available for C. jejuni. Given its status as a leading cause of bacterial
gastroenteritis and its widespread prevalence in nature, the inability to characterise and
track dangerous C. jejuni populations is a major knowledge gap in our understanding of
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the epidemiology of campylobacteriosis, and a detriment to overall Campylobacter-
associated disease management in Canada.
With the advent of inexpensive and accurate whole genome sequencing, Genome-
Wide Association Studies (GWAS) are increasingly being implemented to study bacterial
genomics as tools for the identification of genetic markers associated with a phenotype of
interest. A GWAS represents - compares all genomic content
between test and control groups to identify genetic factors that are statistically associated
- approach where certain
genetic factors are manipulated to test their effect on the phenotype. The utility of the
GWAS approach lies in the ability to rapidly test large numbers of genetic factors, and
potentially identify novel associations between genetic factors and a phenotype under
study (Read & Massey, 2014). GWAS have been utilised to identify mutations and other
polymorphisms associated with antibiotic resistance in Mycobacterium tuberculosis
(Farhat et al., 2013), Staphylococcus aureaus (Alam et al., 2014), and Streptococcus
pneumonia (Chewapreecha et al., 2014). In Campylobacter, GWAS have been used to
identify genetic factors related to Guillain-Barré Syndrome (Taboada et al., 2007), host
adaptation in C. jejuni and C. coli (Sheppard et al., 2013), and markers associated with
the survival of C. jejuni in the poultry production chain (Yahara et al., 2017).
In this thesis, isolates from the C3GFdb were used to perform a GWAS aimed at
identifying genes preferentially found amongst C. jejuni isolates from lineages associated
with human disease. In addition with the goal of using them as diagnostic markers in a
molecular-based risk assessment assay for the rapid detection of human-pathogenic C.
jejuni isolates, identification of such genes could lead to insights in the molecular
mechanisms behind the ecology and pathogenesis of this organism.
36
1.8.1 Research Objectives
1.8.1.1 Chapter 2: A Genome-wide association study to identify diagnostic markers
for human-pathogenic Campylobacter jejuni strains
1) A dataset composed of 166 C. jejuni isolates representing 34 of the 100 most
prevalent CGF subtypes circulating in Canada were selected for WGS. These
subtypes represent approximately 31% of all isolates in the C3GFdb, and over 55%
of isolates from the 100 most prevalent subtypes. Isolates were selected from Non-
Clinically- , Undefined (UN; 5 25%
human clinical isolates), and Clinically-
isolates) CGF subtypes.
2) The WGS data were processed and a pan-genome (n=3,358) for the dataset was
established. The distribution of the accessory genome content (n=1,981) was
determined and used in a GWAS to identify genes (n=28) statistically-significantly
associated with CGF subtypes comprising isolates that cause disease in humans.
3) The availability of thousands of additional draft genome assemblies (n=3,902) from
our laboratory and other public repositories presented an opportunity to conduct an
in silico validation of the putative diagnostic markers against a much larger, and
more geographically and genetically diverse dataset. In total, 25 markers were
considered robust enough for testing in the wetlab.
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1.8.1.2 Chapter 3: Laboratory validation and implementation of a molecular-based
risk assessment assay for the identification of human-pathogenic Campylobacter
jejuni strains
4) PCR primers were designed for each putative diagnostic marker (n=28), and
organised into multiplex PCRs (n=6) for testing in the wetlab. The multiplex PCRs
were optimised, then validated against a panel of 362 strains, including 221 strains
that were previously sequenced. In order to streamline the assay, a subset
comprising the most robust markers (n=11) were re-organised into two new
multiplex PCRs and deployed as the Campylobacter jejuni Risk Assessment
(CJRA) assay.
5) The CJRA Assay was screened against additional C. jejuni strains (n=591) collected
National Microbial
Baseline Study in Broiler Chicken (CFIA, 2016).
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Chapter 2
2 A Genome-wide association study to identify diagnostic markers for human-
pathogenic Campylobacter jejuni strains
2.1 Abstract
Campylobacter jejuni is a leading human enteric pathogen worldwide and despite
an improved understanding of its biology, ecology, and epidemiology, limited tools exist
for identifying strains that are likely to cause disease. In the current study, we used
subtyping data in a database representing over 24,000 isolates collected through various
surveillance projects in Canada to identify 166 representative genomes from prevalent C.
jejuni subtypes for whole genome sequencing. The sequence data was used in a Genome-
Wide Association Study (GWAS) aimed at identifying accessory gene markers associated
with clinically-related C. jejuni subtypes. Prospective markers (n=28) were then
validated against a large number (n=3,902) of clinically-associated and non-clinically-
associated genomes from a variety of sources. A total of 25 genes, including six sets of
genetically linked genes, were identified as robust putative diagnostic markers for
clinically-related C. jejuni subtypes. Although some of the genes identified in this study
have been previously shown to play a role in important processes such as iron acquisition
and vitamin B5 biosynthesis, others have unknown function or are unique to the current
study and warrant further investigation. As few as four of these markers could be used in
combination to detect up to 90% of clinically-associated isolates in the validation dataset,
and such markers could form the basis for a screening assay to rapidly identify strains that
pose an increased risk to public health. The results of the current study are consistent
64
with the notion that specific groups of C. jejuni strains of interest are defined by the
presence of specific accessory genes.
2.2 Introduction
Although molecular epidemiological evidence suggests that not all C. jejuni strains
or genetic lineages pose an equal risk to human health, our current understanding of C.
jejuni subtype-dependent pathogenesis is incomplete (French et al., 2005; Sheppard et al.,
2012). In contrast to other enteric pathogens, C. jejuni does not possess a number of the
classical virulence factors (e.g. Type III or Type IV Secretion Systems, enterotoxins)
found in other pathogens (Havelaar et al., 2009). Previous studies have identified genetic
determinants that are important for C. jejuni pathogenicity (Dasti et al., 2009), but they
are generally conserved across the species. Therefore, these factors have little predictive
power for the identification of isolates with a higher propensity to cause disease in
humans.
With the advent of inexpensive and high-throughput whole genome sequencing,
Genome-Wide Association Studies (GWAS) are increasingly being applied to bacterial
genomics as tools for the identification of genetic markers associated with a phenotype or
trait of interest (Read & Massey, 2014). For example, GWAS have been utilised to
identify mutations and other polymorphisms associated with antibiotic resistance in
Mycobacterium tuberculosis (Farhat et al., 2013), Staphylococcus aureus (Alam et al.,
2014) and Streptococcus pneumoniae (Chewapreecha et al., 2014). In Campylobacter,
GWAS have been used to identify genetic factors related to the Guillain-Barré Syndrome
(Taboada et al., 2007), host adaptation in C. jejuni and Campylobacter coli (Sheppard et
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al., 2013), and more recently, used to identify markers associated with the survival of C.
jejuni in the poultry production chain (Yahara et al., 2017).
In this study, we have used isolates from the Canadian Campylobacter Comparative
Genomic Fingerprinting Database (C3GFdb) to perform a GWAS aimed at identifying
genetic determinants preferentially found among C. jejuni lineages associated with human
disease. The goal of the current study was to identify accessory genes with a statistically
significant difference in carriage rates in two C. jejuni cohorts that differ in terms of their
association with human campylobacteriosis. These genes could be used as diagnostic
markers for molecular-based risk assessment and the rapid detection of C. jejuni isolates
that pose the greatest risk to human health.
2.3 Materials and methods
2.3.1 Strain selection
A total of 166 C. jejuni isolates representing 34 of the 100 most prevalent CGF
subtypes circulating in Canada were selected from the C3GFdb for whole genome
sequencing (Supplementary Table 2.1). The selected isolates and their respective
subtypes represented approximately 31% (7,407/24,142) of all isolates in the database
and over 55% (7,407/13,367) of the isolates from the 100 most prevalent CGF subtypes
(Figure 2.1). They have been observed in multiple provinces, sources and hosts, and over
multiple years, suggesting that they are endemic and in wide circulation. The dataset
selected for WGS was composed of 72 isolates from animals or retail meat, 54 isolates
from environmental sources, and 40 isolates from human clinical cases (Table 2.1).
%HumanClinical
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Table 2.1: Epidemiological characteristics of 34 CGF subtypes targeted for whole-genome
sequencing based on the Canadian Campylobacter Comparative Genomic Fingerprinting
Database (C3GFdb).
CGF Subtype Cohort1
Cluster
Size2
Cluster
Rank3
H A E U
0169.001.002 CA 837 1 30.8% 62.7% 6.3% 0.1%
0695.006.001 UN 709 2 13.7% 80.4% 5.9% 0.0%
0083.001.002 UN 655 3 15.9% 83.2% 0.8% 0.2%
0926.002.001 UN 636 4 9.0% 74.2% 16.8% 0.0%
0044.003.001 CA 373 6 59.0% 40.5% 0.5% 0.0%
0957.001.001 UN 349 7 5.7% 69.6% 24.6% 0.0%
0853.011.001 UN 272 9 12.5% 87.1% 0.4% 0.0%
0882.005.001 UN 265 10 6.8% 81.1% 9.4% 2.6%
0982.001.002 CA 249 11 26.9% 68.3% 4.8% 0.0%
0811.009.002 NCA 237 12 4.2% 43.9% 51.9% 0.0%
0735.005.001 UN 232 13 19.8% 66.8% 13.4% 0.0%
0253.004.001 UN 230 14 21.7% 75.2% 3.0% 0.0%
0960.007.001 UN 224 15 15.2% 76.8% 5.4% 2.7%
0731.001.005 UN 221 16 13.6% 81.9% 4.5% 0.0%
0923.002.001 UN 206 18 8.3% 61.7% 30.1% 0.0%
0269.004.001 CA 154 24 36.4% 63.6% 0.0% 0.0%
0811.008.001 NCA 135 26.5 0.7% 45.9% 53.3% 0.0%
0173.004.001 CA 123 31 30.9% 57.7% 11.4% 0.0%
0173.002.004 UN 116 32.5 23.3% 76.7% 0.0% 0.0%
0933.004.002 CA 108 36 29.6% 65.7% 4.6% 0.0%
0893.001.001 UN 102 37 9.8% 82.4% 7.8% 0.0%
0933.008.001 UN 98 40 22.4% 75.5% 2.0% 0.0%
0949.001.002 UN 94 41 16.0% 72.3% 11.7% 0.0%
0960.003.002 UN 92 42.5 13.0% 67.4% 19.6% 0.0%
0904.002.002 UN 87 44 11.5% 74.7% 12.6% 1.1%
0103.001.002 CA 82 48.5 32.9% 67.1% 0.0% 0.0%
0077.001.003 CA 81 51 33.3% 66.7% 0.0% 0.0%
0238.007.002 UN 75 55.5 20.0% 80.0% 0.0% 0.0%
0260.007.001 UN 75 55.5 21.3% 78.7% 0.0% 0.0%
0844.001.001 NCA 68 63 1.5% 23.5% 75.0% 0.0%
0253.001.002 CA 61 69.5 29.5% 68.9% 0.0% 1.6%
0535.001.003 UN 55 76.5 9.1% 36.4% 54.5% 0.0%
0817.003.001 NCA 55 76.5 0.0% 20.0% 80.0% 0.0%
0083.007.001 CA 51 81 58.8% 41.2% 0.0% 0.0%
Proportion of isolates in subtype (%)4
1 Cohorts: Clinically Associated (CA); Non-Clinically Associated (NCA); Undefined (UN). 2 Number of
isolates observed with the CGF subtype in the C3GFdb. 3 Rank of CGF subtype (based cluster size) in
the C3GFdb. 4 Proportion of isolates in the subtype from Human (H), Animal (A), Environmental (E),
and Unknown (U) sources.
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2.3.2 Genome sequencing, assembly and annotation
Sequencing was conducted at Canada's Michael Smith Genome Sciences Centre,
Vancouver, Canada using the Illumina HiSeq 2000 platform. Whole genome sequence
data for this study has been deposited in the Sequence Read Archive (SRA) at the
National Center for Biotechnology Information (NCBI) under the BioProject
PRJNA368735. Draft de novo genome assembly of paired-end reads was performed
using SPAdes v.2.4.0 (Bankevich et al., 2012) with pre-assembly BayesHammer read
correction, default k-mer size testing options, and post-assembly Burrows Wheeler
Aligner mismatch correction. Contigs with low coverage or shorter than 500 bp were
removed from all subsequent analyses. Genome assembly quality was assessed using
QUAST v.2.1 (Gurevich et al., 2013). Prediction of Open Reading Frames (ORFs) and
annotation was performed using the PROKKA pipeline v.1.5.2 (Seemann, 2014) using a
custom database of non-redundant gene sequences representing five complete and well-
annotated C. jejuni reference genomes available from NCBI (Supplementary Table 2.2).
2.3.3 Definition of a C. jejuni reference pan-genome for the dataset
Predicted ORFs were queried using a reciprocal best hit approach (Moreno-
Hagelsieb & Latimer, 2008; Ward & Moreno-Hagelsieb, 2014) with BLAST v 2.2.29
(Camacho et al., 2009) in order to define a reference pan-genome, the non-redundant set
of genes for a set of genome sequences (Méric et al., 2014). Paired BLAST queries were
treated as orthologous
coverage and a single exemplar was included in the pan-genome. The pan-genome
defined using this process was used in the subsequent GWAS.
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2.3.4 Genome-wide association study
Carriage across the dataset of all genes representing the pan-genome was assessed
by BLAST analysis. The nucleotide sequence of each gene was queried against the 166
draft genome assemblies using Blastn. Genes were considered to be present if a hit
found and considered absent otherwise. In order to facilitate statistical comparison,
subtypes were defined as either Non-Clinically
isolates), Undefined (UN; 5-25% human clinical isolates), or Clinically Associated (CA;
defined based on its carriage rate in the CA and NCA cohorts and was computed using
(https://bitbucket.org/peterk87/genomefisher/wiki/Home); p-values were adjusted for
multiple testing using the method of Holm (Aickin & Gensler, 1996; Gaetano, 2013;
Holm, 1979). Statistically significant genes were subjected to further analysis and
validation as outlined below.
2.3.5 In silico validation of putative diagnostic marker genes.
In order to select markers with the highest potential for downstream assay
development, candidate genes identified by the GWAS analysis were filtered in a
stepwise process according to the following conditions: 1) complete absence in the NCA
complete, or near complete, conservation of sequence length (>90%) in the corresponding
orthologous gene, when present, among a set of reference genomes (Table 2.2); and 3)
statistical significance (p < 0.05) when the NCA cohort was compared to a combined
70
CA+UN cohort, in which the UN (i.e. undefined) genomes were treated as CA and pooled
with the CA genomes. Genes that passed all criteria were selected for an in silico
validation using a larger set of genome sequences. This validation dataset was created by
combining genomes sequenced in house as part of current or previous studies (n=325)
and additional genomes acquired from public repositories (n=3,955). Publicly available
genomes were restricted to those with available epidemiological data (e.g. sample source,
country of origin, etc.). To facilitate assignment into NCA, UN, and CA cohorts, in silico
CGF was performed on these genomes using MIST (Kruczkiewicz et al., 2013), with a
concordance between CGF profiles predicted in silico and those generated in the
laboratory estimated to be 96.8% on a subset of 325 isolates (12,583/13,000 matching
loci; data not shown); only genomes from CGF subtypes previously observed in the
C3GFdb were retained in the validation set (n=3,902). Each genome was designated to
its respective cohort based on the corresponding epidemiological data of the in silico CGF
subtype. Finally, the putative diagnostic genes identified by the GWAS using the original
set of 166 genomes were tested for statistically significance with the expanded cohorts.
The combinatorial effect of different subsets of markers was also assessed to determine if
a reduced number of markers could be applied to detect clinically-related C. jejuni
subtypes without a subsequent loss of sensitivity.
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2.4 Results and discussion
2.4.1 Genome sequencing, assembly and annotation.
The quality of the de novo assembly of the 166 genomes selected as representatives
of 34 highly prevalent CGF subtypes in Canada was assessed using QUAST (Gurevich et
al., 2013). The average number of reads produced for each genome was 4,161,271
(±1,223,304), for an average coverage of 253x (±74.7x). Individual genome assemblies
had an average of 67 (±27) contigs and an N75 of 34,631 bp (± 13,815 bp). All genome
assemblies had additional parameters in range with what has typically been observed for
C. jejuni. The average assembly length (1,660,986 ±51,283.5 bp), predicted ORFs
(1,719±71), and %G+C (30.4±0.13%) were typical of C. jejuni genome assemblies
available in the public domain. Annotation of the 166 draft genomes from this study
using the PROKKA pipeline (Seemann, 2014) resulted in the identification of 291,502
ORFs. The genome of strain NCTC 11168, which has been completely sequenced
(Parkhill et al., 2000), was included in the analysis as a control to assess the completeness
of the ORF prediction and annotation process. The original annotation of NCTC 11168
predicted 1,654 ORFs, while a subsequent re-annotation predicted 1,643 ORFs
(Gundogdu et al., 2007); in our analysis, the PROKKA pipeline predicted 1,659 ORFs.
This small discrepancy is related to the advanced curation used in the re-annotation of
NCTC 11168, which resulted in the merging and removal of coding sequences belonging
to pseudogenes and phase variable genes. The pan-genome established using this dataset
consisted of 3,358 unique ORFs, of which 1,377 were present in all genomes (i.e. core
genes) and 1,981 were present in a varying number of genomes (i.e. accessory genes).
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2.4.2 Genome-wide association study
Of the 166 C. jejuni isolates selected for this study, 35 were assigned to the NCA
cohort and represented four different CGF subtypes, 80 were assigned to the UN cohort
and represented 20 CGF subtypes, and 51 were assigned to the CA cohort and represented
ten CGF subtypes (Table 2.1). A GWAS was performed in order to identify accessory
genes with a biased distribution in CA and NCA cohorts. Although in principle GWAS
can be used to identify genetic variation ranging from SNPs to indels involving multiple
genes, we chose to focus on accessory genes, as they have excellent potential for the
development of rapid, robust, and inexpensive PCR-based diagnostic assays for screening
of large numbers of strains. At the same time, it is important to note that other forms of
genetic variation may represent valuable targets for tracking strains of interest. Recently,
Clark et al. showed that large-scale chromosomal inversion could be used to distinguish a
subset of outbreak-associated isolates from epidemiologically unrelated co-circulating
isolates (Clark et al., 2016).
In total, 595 genes showed statistically significant differences in carriage between
NCA and CA cohorts (p < 0.05) (Figure 2.2). Of these, 71 genes were completely absent
(Condition 1), and 63 of these genes also maintained high sequence identity (>99%) and
near complete sequence coverage (>90%) compared to their respective reference genes
(Condition 2). Of these, 28 continued to exhibit robust statistical significance when the
NCA cohort was compared to a pooled cohort comprising all UN and CA genomes
(Condition 3). These included six sets of genes that appear to be found in linkage groups
(LGs) (Table 2.2), with members of each linkage group possessing similar rates of
carriage in the dataset. Since linked genes, which are located adjacently on the
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chromosome, tend to be functionally related and are typically transmitted as a functional
unit (Muley & Acharya, 2013), it is likely that their identification in this study was not
due to spurious statistical signal.
Among the linkage groups observed in the GWAS were two sets of genes
responsible for encoding iron acquisition systems. We observed that genes encoding both
the TonB1-mediated Cj0178 (LG2; Cj0177 Cj0181) and the TonB3-mediated CfrA
(LG6; Cj0753c/Cj0755) iron acquisition systems were significantly associated with C.
jejuni isolates from clinically-related CGF subtypes. As is the case in most pathogens,
iron acquisition is considered to be a virulence determinant in C. jejuni and has been
linked to successful colonisation in vivo (Kim et al., 2003; Naikare et al., 2006; Palyada et
al., 2004). CfrA has been shown to be capable of transporting a wide variety of
structurally different siderophores, which may contribute to the ability of isolates with
these genes to colonise a wide variety of hosts/niches (Naikare et al., 2013).
Another linkage group associated with CA and UN subtypes was composed of
genes that encode the pantothenate (vitamin B5) biosynthesis pathway and -lactam
antibiotic resistance. LG5 encompasses a total of five genes, including a putative
acetyltransferase (Cj0295), the panBCD operon (Cj0296c Cj0298c), which encodes for
the pantothenate (vitamin B5) biosynthesis pathway, as well as the gene blaOXA-61
(Cj0299), -lactam antibiotics.
P-value P-value
76
These genes were recently implicated in host adaptation in C. jejuni and C. coli,
where they were found to be more strongly associated with cattle-specific lineages
relative to chicken-specific lineages, possibly as a result of selective pressures created by
contemporary and geographically-dependent agricultural practices (Sheppard et al.,
2013). Although it is generally recognised that chickens are a primary source of human
exposure leading to infection, we observed strong statistical signal among CA subtypes
for genes previously identified as cattle-associated (Sheppard et al., 2013). Sheppard et
al. suggested that maintenance of these genes in chickens, albeit at a reduced rate, may
facilitate rapid host switching as part of a host-generalist strategy. Moreover, we have
observed that a majority of the most prevalent clinically-related CGF subtypes, many of
which are represented in our GWAS dataset, are associated with both cattle and chickens.
This is consistent with the possible role of cattle as an important reservoir for strains that
go on to contaminate the chicken production system, ultimately leading to human cases of
campylobacteriosis. As this manuscript was being readied for publication, GWAS was
used to identify several loci that could be used as -
markers for source attribution (Thépault et al., 2017). Interestingly, one of the loci
(Cj0260c) was also identified in our analysis. Thus, while our data suggests that presence
of this gene is strongly associated with human clinical isolates, data from the study by
Thépault et al. further suggests the allelic information appears to highly predictive of host
source.
2.4.3 In silico validation of putative diagnostic marker genes
Population structure has been identified as a potential confounding factor in GWAS
analyses, in that statistically significant associations may ultimately be due to
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oversampling of certain subpopulations rather than with the phenotypic trait under
investigation (Read & Massey, 2014). Since the focus of the current study was the
examination of prevalent C. jejuni subtypes in Canada in the context of population
structure, it was necessary to exclude the possibility that the markers we identified
represent a biased distribution resulting from oversampling within certain lineages in the
population. The large-scale marker validation that we performed using available WGS
data included a dataset composed of genomes largely from the United Kingdom
(3,871/4,280; 90%) and Canada (327/4,280; 8%), and an overwhelming majority of
isolates were recovered from human clinical sources (3,559/4,280; 83%), while those
from animal (626/4,280; 15%) and environmental (95/4,280; 2%) sources made up the
remainder. A total of 539 CGF subtypes were identified by in silico CGF, however, 279
subtypes were novel and had not been previously observed in the C3GFdb and were
omitted from the analysis since their epidemiological characteristics could not be
determined. Of the remaining 260 CGF subtypes, 38 CGF subtypes (160 genomes) were
identified as NCA, nine CGF subtypes (99 genomes) were identified as UN, and 213 CGF
subtypes (3,742 isolates) were identified as CA. Despite the influx of genetically and
geographically diverse isolates introduced as part of the expanded dataset, a majority
(n=25) of the markers in the original GWAS analysis continued to show statistical
significance with CA subtypes; on average these markers were present in 73% of CA
isolates compared to only 36% of NCA isolates (Figure 2.3). Moreover, results of our
combinatorial marker analysis show that as few as four markers could be used in
combination to detect up to 90% of CA isolates in the validation dataset, with a modest
carriage rate of 21% among NCA isolates. These findings suggest that the robust signal
detected in the original GWAS analysis stems from genes that appear to have diagnostic
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value for the identification of C. jejuni subtypes with an increased association with
campylobacteriosis.
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2.5 Conclusion
A major challenge in the prevention and control of campylobacteriosis is our
current inability to identify strains of C. jejuni that pose greatest risk to human health.
Addressing this issue would pave the way to better tracking of high-risk strains, leading
to a better understanding of their distribution in the food chain and providing critical
information towards the development of targeted mitigation strategies to reduce human
exposure.
The goal of this study was to identify markers associated with C. jejuni lineages
known to cause disease in humans and that have a high prevalence in Canada. The
genomes of 166 isolates representing 34 highly prevalent C. jejuni subtypes were
sequenced and a GWAS was performed to identify 28 genes significantly associated with
highly-prevalent and clinically-related C. jejuni subtypes. While some putative gene
markers identified as part of this study have previously been associated with important
aspects of C. jejuni biology including iron acquisition and vitamin B5 biosynthesis, others
represent putative proteins associated with catalysis and transport, which may play roles
in processes important for infection and warrant further investigation.
Although these genes were identified within a dataset of Canadian origin, 25 of
them continued to display strong statistical significance when validated against a more
genetically and geographically diverse dataset. This suggests that they may represent
robust markers for clinically associated C. jejuni subtypes, paving the way for future
development of molecular assays for rapid identification of C. jejuni strains that pose an
increased risk to human health.
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2.7 Supplementary information
Table S2.1: Characteristics and NCBI accession numbers for strains characterised by
whole genome sequencing.
Strain CGF Subtype Clinical Relevance Host Isolation Year Isolation Location Accession Number
C3GFDB009514 0083.007.001 CA Human 2007 Ontario SAMN06270746
C3GFDB009574 0083.007.001 CA Chicken 2007 Ontario SAMN06270747
C3GFDB008268 0103.001.002 CA Cow 2010 Ontario SAMN06270748
C3GFDB016493 0253.001.002 CA Human 2005 Alberta SAMN06270749
C3GFDB016524 0077.001.003 CA Human 2005 Alberta SAMN06270750
C3GFDB016539 0077.001.003 CA Human 2005 Alberta SAMN06270751
C3GFDB016546 0253.001.002 CA Human 2005 Alberta SAMN06270752
C3GFDB016564 0933.004.002 CA Human 2005 Alberta SAMN06270753
C3GFDB016571 0044.003.001 CA Human 2005 Alberta SAMN06270754
C3GFDB016572 0169.001.002 CA Human 2005 Alberta SAMN06270755
C3GFDB016592 0169.001.002 CA Human 2005 Alberta SAMN06270756
C3GFDB016601 0169.001.002 CA Human 2005 Alberta SAMN06270757
C3GFDB016634 0169.001.002 CA Human 2005 Alberta SAMN06270758
C3GFDB017536 0269.004.001 CA Human 2004 Alberta SAMN06270759
C3GFDB017537 0269.004.001 CA Human 2004 Alberta SAMN06270760
C3GFDB017540 0044.003.001 CA Human 2004 Alberta SAMN06270761
C3GFDB017542 0173.004.001 CA Human 2004 Alberta SAMN06270762
C3GFDB017610 0269.004.001 CA Human 2005 Alberta SAMN06270763
C3GFDB017620 0044.003.001 CA Human 2005 Alberta SAMN06270764
C3GFDB017638 0169.001.002 CA Human 2005 Alberta SAMN06270765
C3GFDB017646 0933.004.002 CA Human 2005 Alberta SAMN06270766
C3GFDB014399 0173.004.001 CA Cow 2004 Alberta SAMN06270767
C3GFDB014501 0044.003.001 CA Cow 2004 Alberta SAMN06270768
C3GFDB014638 0269.004.001 CA Cow 2004 Alberta SAMN06270769
C3GFDB014681 0269.004.001 CA Cow 2005 Alberta SAMN06270770
C3GFDB014710 0044.003.001 CA Cow 2005 Alberta SAMN06270771
C3GFDB014716 0169.001.002 CA Cow 2005 Alberta SAMN06270772
C3GFDB014747 0933.004.002 CA Sheep 2005 Alberta SAMN06270773
C3GFDB014751 0044.003.001 CA Cow 2005 Alberta SAMN06270774
C3GFDB014892 0169.001.002 CA Chicken 2006 Alberta SAMN06270775
C3GFDB014897 0169.001.002 CA Chicken 2006 Alberta SAMN06270776
C3GFDB014986 0269.004.001 CA Cow 2011 Alberta SAMN06270777
C3GFDB015015 0269.004.001 CA Cow 2011 Alberta SAMN06270778
C3GFDB015022 0253.001.002 CA Cow 2011 Alberta SAMN06270779
C3GFDB015057 0253.001.002 CA Cow 2011 Alberta SAMN06270780
C3GFDB015090 0253.001.002 CA Cow 2011 Alberta SAMN06270781
C3GFDB015145 0269.004.001 CA Cow 2011 Alberta SAMN06270782
C3GFDB015154 0269.004.001 CA Cow 2011 Alberta SAMN06270783
C3GFDB015165 0269.004.001 CA Cow 2011 Alberta SAMN06270784
C3GFDB015192 0269.004.001 CA Cow 2011 Alberta SAMN06270785
C3GFDB015200 0269.004.001 CA Cow 2011 Alberta SAMN06270786
C3GFDB015228 0169.001.002 CA Cow 2012 Alberta SAMN06270787
C3GFDB015257 0169.001.002 CA Cow 2012 Alberta SAMN06270788
C3GFDB015303 0169.001.002 CA Cow 2012 Alberta SAMN06270789
C3GFDB015390 0173.004.001 CA Cow 2012 Alberta SAMN06270790
C3GFDB016536 0982.001.002 CA Human 2005 Alberta SAMN06270791
C3GFDB016537 0982.001.002 CA Human 2005 Alberta SAMN06270792
C3GFDB014656 0982.001.002 CA Cow 2005 Alberta SAMN06270793
C3GFDB014661 0982.001.002 CA Cow 2005 Alberta SAMN06270794
C3GFDB015708 0982.001.002 CA Water 2005 Alberta SAMN06270795
C3GFDB016010 0982.001.002 CA Water 2010 Alberta SAMN06270796
C3GFDB014551 0817.003.001 NCA Goose 2004 Alberta SAMN06270797
C3GFDB014554 0817.003.001 NCA Goose 2004 Alberta SAMN06270798
C3GFDB014559 0817.003.001 NCA Goose 2004 Alberta SAMN06270799
C3GFDB015571 0811.009.002 NCA Water 2004 Alberta SAMN06270800
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Strain CGF Subtype Clinical Relevance Host Isolation Year Isolation Location Accession Number
C3GFDB015649 0817.003.001 NCA Water 2004 Alberta SAMN06270801
C3GFDB015666 0811.009.002 NCA Water 2004 Alberta SAMN06270802
C3GFDB015668 0817.003.001 NCA Water 2004 Alberta SAMN06270803
C3GFDB014630 0811.009.002 NCA Goose 2004 Alberta SAMN06270804
C3GFDB016172 0811.009.002 NCA Water 2006 British Columbia SAMN06270805
C3GFDB015754 0811.009.002 NCA Water 2006 Alberta SAMN06270806
C3GFDB016266 0811.009.002 NCA Water 2006 British Columbia SAMN06270807
C3GFDB014923 0811.008.001 NCA Goose 2006 Alberta SAMN06270808
C3GFDB014927 0811.008.001 NCA Duck 2006 Alberta SAMN06270809
C3GFDB015823 0811.008.001 NCA Water 2006 Alberta SAMN06270810
C3GFDB019796 0844.001.001 NCA Water 2006 Ontario SAMN06270811
C3GFDB019832 0811.009.002 NCA Water 2006 Ontario SAMN06270812
C3GFDB015843 0817.003.001 NCA Water 2006 Alberta SAMN06270813
C3GFDB015846 0811.009.002 NCA Water 2006 Alberta SAMN06270814
C3GFDB016311 0844.001.001 NCA Water 2006 British Columbia SAMN06270815
C3GFDB019847 0811.009.002 NCA Water 2006 Ontario SAMN06270816
C3GFDB015878 0817.003.001 NCA Water 2006 Alberta SAMN06270817
C3GFDB016325 0811.009.002 NCA Water 2006 British Columbia SAMN06270818
C3GFDB015958 0811.008.001 NCA Water 2007 Alberta SAMN06270819
C3GFDB016401 0844.001.001 NCA Water 2007 British Columbia SAMN06270820
C3GFDB016403 0844.001.001 NCA Water 2007 British Columbia SAMN06270821
C3GFDB015968 0844.001.001 NCA Water 2007 Alberta SAMN06270822
C3GFDB015981 0811.008.001 NCA Water 2007 Alberta SAMN06270823
C3GFDB015988 0817.003.001 NCA Water 2007 Alberta SAMN06270824
C3GFDB016437 0817.003.001 NCA Water 2007 British Columbia SAMN06270825
C3GFDB019988 0811.008.001 NCA Water 2008 Ontario SAMN06270826
C3GFDB020240 0811.008.001 NCA Water 2009 Ontario SAMN06270827
C3GFDB016025 0811.009.002 NCA Water 2010 Alberta SAMN06270828
C3GFDB020625 0811.009.002 NCA Water 2010 Ontario SAMN06270829
C3GFDB021309 0811.009.002 NCA Water 2010 Quebec SAMN06270830
C3GFDB020827 0811.008.001 NCA Water 2011 Ontario SAMN06270831
C3GFDB009352 0926.002.001 UN Chicken 2005 Ontario SAMN06270832
C3GFDB009426 0926.002.001 UN Human 2006 Ontario SAMN06270833
C3GFDB009442 0173.002.004 UN Human 2006 Ontario SAMN06270834
C3GFDB009472 0735.005.001 UN Human 2006 Ontario SAMN06270835
C3GFDB009494 0853.011.001 UN Human 2007 Ontario SAMN06270836
C3GFDB008237 0960.003.002 UN Cow 2010 Ontario SAMN06270837
C3GFDB008715 0893.001.001 UN Chicken 2011 Ontario SAMN06270838
C3GFDB008759 0173.002.004 UN Chicken 2011 Ontario SAMN06270839
C3GFDB008776 0923.002.001 UN Chicken 2011 Ontario SAMN06270840
C3GFDB008798 0882.005.001 UN Turkey 2011 Ontario SAMN06270841
C3GFDB008833 0882.005.001 UN Chicken 2011 British Columbia SAMN06270842
C3GFDB008868 0893.001.001 UN Chicken 2011 British Columbia SAMN06270843
C3GFDB016476 0695.006.001 UN Human 2005 Alberta SAMN06270844
C3GFDB016480 0253.004.001 UN Human 2005 Alberta SAMN06270845
C3GFDB016487 0695.006.001 UN Human 2005 Alberta SAMN06270846
C3GFDB016492 0933.008.001 UN Human 2005 Alberta SAMN06270847
C3GFDB016521 0695.006.001 UN Human 2005 Alberta SAMN06270848
C3GFDB016545 0083.001.002 UN Human 2005 Alberta SAMN06270849
C3GFDB016553 0083.001.002 UN Human 2005 Alberta SAMN06270850
C3GFDB016561 0083.001.002 UN Human 2005 Alberta SAMN06270851
C3GFDB016566 0960.007.001 UN Human 2005 Alberta SAMN06270852
C3GFDB016580 0926.002.001 UN Human 2005 Alberta SAMN06270853
C3GFDB016583 0253.004.001 UN Human 2005 Alberta SAMN06270854
C3GFDB016602 0933.008.001 UN Human 2005 Alberta SAMN06270855
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C3GFDB016630 0083.001.002 UN Human 2005 Alberta SAMN06270856
C3GFDB017566 0695.006.001 UN Human 2004 Alberta SAMN06270857
C3GFDB017618 0260.007.001 UN Human 2005 Alberta SAMN06270858
C3GFDB015479 0731.001.005 UN Water 2004 Alberta SAMN06270859
C3GFDB014430 0949.001.002 UN Cow 2004 Alberta SAMN06270860
C3GFDB014444 0949.001.002 UN Cow 2004 Alberta SAMN06270861
C3GFDB015494 0695.006.001 UN Water 2004 Alberta SAMN06270862
C3GFDB014498 0960.007.001 UN Cow 2004 Alberta SAMN06270863
C3GFDB014510 0695.006.001 UN Cow 2004 Alberta SAMN06270864
C3GFDB014519 0238.007.002 UN Sheep 2004 Alberta SAMN06270865
C3GFDB015508 0949.001.002 UN Sewage 2004 Alberta SAMN06270866
C3GFDB014531 0731.001.005 UN Cat 2004 Alberta SAMN06270867
C3GFDB015612 0904.002.002 UN Water 2004 Alberta SAMN06270868
C3GFDB015628 0933.008.001 UN Sewage 2004 Alberta SAMN06270869
C3GFDB014616 0083.001.002 UN Chicken 2004 Alberta SAMN06270870
C3GFDB014624 0083.001.002 UN Chicken 2004 Alberta SAMN06270871
C3GFDB014647 0731.001.005 UN Cow 2005 Alberta SAMN06270872
C3GFDB014687 0695.006.001 UN Cow 2005 Alberta SAMN06270873
C3GFDB014743 0957.001.001 UN Sheep 2005 Alberta SAMN06270874
C3GFDB014764 0957.001.001 UN Cow 2005 Alberta SAMN06270875
C3GFDB014772 0957.001.001 UN Sheep 2005 Alberta SAMN06270876
C3GFDB018263 0535.001.003 UN Water 2006 New Brunswick SAMN06270877
C3GFDB019677 0535.001.003 UN Water 2006 Ontario SAMN06270878
C3GFDB014863 0695.006.001 UN Cow 2006 Alberta SAMN06270879
C3GFDB015779 0960.007.001 UN Water 2006 Alberta SAMN06270880
C3GFDB014881 0926.002.001 UN Goose 2006 Alberta SAMN06270881
C3GFDB014887 0926.002.001 UN Dog 2006 Alberta SAMN06270882
C3GFDB014933 0926.002.001 UN Duck 2006 Alberta SAMN06270883
C3GFDB014939 0926.002.001 UN Chicken 2006 Alberta SAMN06270884
C3GFDB018269 0535.001.003 UN Water 2006 New Brunswick SAMN06270885
C3GFDB019812 0957.001.001 UN Water 2006 Ontario SAMN06270886
C3GFDB015839 0904.002.002 UN Water 2006 Alberta SAMN06270887
C3GFDB019857 0957.001.001 UN Water 2006 Ontario SAMN06270888
C3GFDB015915 0960.007.001 UN Water 2007 Alberta SAMN06270889
C3GFDB019903 0735.005.001 UN Water 2007 Ontario SAMN06270890
C3GFDB014971 0949.001.002 UN Cow 2009 Alberta SAMN06270891
C3GFDB014974 0949.001.002 UN Cow 2009 Alberta SAMN06270892
C3GFDB020075 0731.001.005 UN Water 2009 Ontario SAMN06270893
C3GFDB020274 0957.001.001 UN Water 2009 Ontario SAMN06270894
C3GFDB020424 0535.001.003 UN Water 2010 Ontario SAMN06270895
C3GFDB021276 0535.001.003 UN Water 2010 Quebec SAMN06270896
C3GFDB020474 0957.001.001 UN Water 2010 Ontario SAMN06270897
C3GFDB016023 0535.001.003 UN Water 2010 Alberta SAMN06270898
C3GFDB020618 0957.001.001 UN Water 2010 Ontario SAMN06270899
C3GFDB015045 0695.006.001 UN Cow 2011 Alberta SAMN06270900
C3GFDB015120 0695.006.001 UN Cow 2011 Alberta SAMN06270901
C3GFDB020782 0957.001.001 UN Water 2011 Ontario SAMN06270902
C3GFDB018644 0904.002.002 UN Raccoon 2011 Ontario SAMN06270903
C3GFDB018673 0904.002.002 UN Raccoon 2011 Ontario SAMN06270904
C3GFDB018718 0904.002.002 UN Raccoon 2011 Ontario SAMN06270905
C3GFDB018774 0535.001.003 UN Raccoon 2011 Ontario SAMN06270906
C3GFDB020936 0957.001.001 UN Water 2011 Ontario SAMN06270907
C3GFDB015346 0695.006.001 UN Cow 2012 Alberta SAMN06270908
C3GFDB015373 0695.006.001 UN Cow 2012 Alberta SAMN06270909
C3GFDB015427 0695.006.001 UN Horse 2012 Alberta SAMN06270910
C3GFDB015431 0695.006.001 UN Horse 2012 Alberta SAMN06270911
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Table S2.2: Well-characterised genomes used to generate the reference pan-genome.
Accession Number Species Strain Reference
AL111168.1 C. jejuni jejuni NCTC 11168 Parkhill et al., 2000
NC_003912.7 C. jejuni jejuni RM1221 Fouts et al., 2005
NC_008787.1 C. jejuni jejuni 81-176 Direct Submission
NC_009707.1 C. jejuni doylei 269.97 Direct Submission
NC_009839.1 C. jejuni jejuni 81116 Direct Submission
88
Chapter 3
3 Laboratory validation and implementation of a molecular-based risk assessment
assay for the identification of human-pathogenic Campylobacter jejuni
3.1 Abstract
A major challenge in the prevention and control of campylobacteriosis is our
inability to identify strains that pose the greatest risk to human health. In a previous
study, we conducted a Genome-Wide Association Study (GWAS) to identify genetic
markers associated with C. jejuni strains linked to human illness that could be used in a
molecular-based risk assessment assay. Here, these markers were assembled into six
multiplex PCR assays for wetlab validation using an expanded panel of strains (n=362)
representing Non-Clinically-Associated (NCA) and Clinically-Associated (CA) subtypes
circulating in Canada. These data were used to select a subset of the best-performing
markers (n=11), which were re-organised into two multiplex PCRs comprising the
finalised Campylobacter jejuni Risk Assessment (CJRA) Assay. The CJRA Assay was
then deployed to screen field isolates (n=601) collected as part of the Canadian Food
A) Microbial Baseline Survey in poultry. Overall, the assay
detected 99.7% (579/581) of strains classified as being clinically associated, and 64.7%
(247/382) of strains classified as being non-clinically associated. The detection of
human-pathogenic strains belonging to subtypes not previously associated with human
illness (i.e. those that are novel or emerging), highlights the utility of the risk assessment
assay to identify high-risk strains in the absence of other supporting metadata used to
infer risk.
89
3.2 Introduction
A major challenge in the prevention and control of campylobacteriosis is the
inability to identify pathogenic C. jejuni strains, especially in light of molecular
epidemiological evidence that suggests not all C. jejuni strains or genetic lineages pose an
equal risk to human health (Buchanan et al., 2017; French et al., 2005; Sheppard et al.,
2012). Unlike other enteric pathogens, for which there are well-described features (i.e.
virulence factors or specific serotypes) linked to human disease that are used as markers
in risk assessment assays, no such tool exists for C. jejuni. Addressing this issue would
result in better tracking of high-risk strains, leading to a better understanding of their
distribution in the food chain, and provide critical data for the development of targeted
mitigation strategies to reduce human exposure to C. jejuni.
The previous chapter described a Genome-Wide Association Study (GWAS)
designed to identify genetic markers that could be used in a molecular-based risk
assessment (MRA) assay for C. jejuni. The gene content between strains from prominent
non-pathogenic and pathogenic subtypes was compared, which resulted in the
identification of 28 putative diagnostic markers that were statistically significantly linked
to strains from subtypes associated with human illness. These markers were subjected to
an in silico validation using a much larger and epidemiologically diverse dataset
composed of all available WGS data that possessed sufficient epidemiological metadata
exhibit robust diagnostic behaviour for the identification of pathogenic C. jejuni strains.
In the current study, the markers described above were implemented as a wetlab
assay and subjected to additional validation before being used to screen a large panel of
90
Baseline Study (MBS) in broiler chicken (CFIA, 2016).
3.3 Materials and methods
3.3.1 Putative diagnostic markers
A detailed description of methods used to identify the putative diagnostic markers is
described in Chapter 2 (Buchanan et al., 2017). Briefly, 166 strains representing 34
highly prevalent subtypes circulating in Canada were selected for whole genome
sequencing. The non-redundant pan-genome was defined for the dataset, and a GWAS
was conducted to compare the distribution of gene content between cohorts of strains
from Non-Clinically-Associated (NCA; <5% human clinical isolates) and
Undefined/Clinically-
identify genes that were statistically significantly associated with the latter. A total of 28
putative diagnostic markers were identified and validated in silico (Table 3.1).
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3.3.2 Primer and multiplex PCR assay design
Orthologous sequences from the draft genome assemblies and NCTC 11168 for
each putative diagnostic marker were identified by homology searching with BLAST v
2.2.29 (Camacho et al., 2009). Paired BLAST queries were treated as orthologous if they
-sequence
alignment (MSA) for each set of orthologues was generated using MAFFT v. 7.245
(Katoh & Standley, 2013) and a consensus sequence was generated from each MSA using
BioEdit v. 7.2.5 (Hall, 1998). The consensus sequences representing the putative
diagnostic markers were split into six groups such that each group was composed of a
range of short to long gene sequences to promote primer design that would yield
amplicons of staggered size to facilitate scoring on agarose gels. The PrimerPlex Module
in AlleleID v 7.83 (Premier Biosoft International, Palo Alto, CA, USA) was used to
design primers suitable for multiplexing with the following guidelines: a length of 25-30
bp, a melting temperature between 57-61°C and with minimal self- and hetero-
dimeris -8.0 kcal/mole). Amplicons within a multiplex had to fall
between 100 bp 1000 bp in length with a minimum size difference of at least 30 bp.
Specificity of the primers was assessed using NCBI BLAST
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) against the C. jejuni taxid (197).
3.3.3 Multiplex PCR optimisation
Each of the six multiplex PCR assays (MP1-MP6; Table 3.2) was optimised for
primer concentration, magnesium concentration, annealing temperature, cycle number
and extension time (data not shown). A panel of 11 strains with corresponding whole
genome sequence data was used to validate the multiplex PCRs during the optimisation
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process. The optimised multiplex PCR mixtures consisted of 1 µL of nucleic acid, 0.2 µL
of Taq Polymerase (MP Biomedicals, Solon, OH, USA), either 1.5 mM MgCl2 for MP5
or 3.0 mM MgCl2 for all other multiplexes (MP Biomedicals), 0.2 mM of each dNTP
(Invitrogen, Burlington, ON, CAN), 0.2 µM of each primer (IDT DNA Technologies,
Coralville, IA, USA) in 10 x reaction buffer (MP Biomedicals) with PCR-grade water to a
final volume of 25 µL. PCR was carried out with a pre-denaturation stage of 94°C for 5
min followed by 30 cycles of 94°C for 30 s, 65°C for 30 s, 72°C for 1 min, with a final
extension step of 72°C for 5 min on the Mastercycler Pro thermal cycler (Eppendorf,
Mississauga, ON, CAN). PCR amplified material was assayed on the QIAxcel Capillary
Gel Electrophoresis System (QiAgen, Mississauga, ON, CAN) with the DNA Screening
Kit (QiAgen) for visualisation of the amplification products; markers were scored as
present if a PCR product of the correct size was observed.
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Table 3.2: The multiplexed PCR primers used to screen strains for the putative diagnostic
markers. MP1-F and MP2-F represent the finalised multiplex PCR assays for the
Campylobacter jejuni Risk Assessment (CJRA) Assay.
Multiplex Marker Forward Reverse Amplicon Size
MP1 11168_00169 GTTAGCAAGCACAGAGCAAAATCACTT CAATACATCAGCCATACGCCTGTCT 373
11168_00170 GGGTGGCAAGATAGGTAGTAGTATGGT AAGCAGGTCTGTGTCCTTTGATATTCC 623
11168_00172 ACAAAGAAGAGGAGTTAAGTGAGATCAA ACTTGTGATAAGAGGAGTAACAGCCATA 101
11168_00718 AACCCACACAAACTATACAAGAGCCTTC AAGAACCTCCCCACTCATACGCATT 314
11168_01201 CGGAGAACCTACAACAGAACAAAAACAA TCCACCTAGTCCGTAATTATCCGTATCG 139
MP2 11168_00051 AGGTGCTTTGCCTTATCGTGGAAAA ACCCATAGCCATTTCGTATTCTTTCACA 400
11168_00244 TTGGACGCTTGATTCTTGATGCAATT ACTGACTATCAATGACAATAAACCAGCT 119
11168_00248 TCCTTTACAGCACTATACCGCCGATA TCCACTTGATTTCCAGCCATAACTTCC 241
11168_00281 ACTTTCTCTCCCGCTTCCACTTTTAA TTGATACCAATTCTTCTTGCCACTTCTT 209
MP3 11168_00173 CAAGGAGCGGAATTTACTTCCATTATGA ATCTTTATTACTTTGTAGCGGAGCACTG 282
11168_00249 TACCGCCTATACCGATGAAGTTGTATC AATCACAGAAGGTGCTTTAGGATTTACA 166
11168_00277 GCAGAAATTGCTTGATTTGCTTTTTACT TTTTGTCCCTCTTTGATAACCTTGTTTT 198
11168_01519 CTTACGAGAGATTAAACGCCTTGAAAGC ACGCCCTAGTTCTTGGTATAATGCTAAG 356
06_7515_00723 TGAAACAATAGCTGAACGCAAAACACTT TGGCACTGACACTAGCAAGAATTGATTT 803
MP4 11168_00171 ATCAAAATGCTGATGAGGTGGTAAAAGG TGCTGTGATTTGCTTTGAGATGGTATTT 305
11168_00230 GTCTAGGTGAAATGGAAGGAGCTATCAA TCAAAATCTTCGCTGACATTGCTTCTTT 205
11168_00703 GCCTGATGATCTTACGCTTAAATGGTAT GTATCCAAGCTGTGCCTCCTATATTGTC 275
11168_01309 GGAACTTCTATGGCAGCACCTATGG TCCTTGCACGGTTAAATCATTCAAATCT 870
06_2866_00597 GTGGATGGCTTGCGGATAATTACTTAG AGTGTATTGTTGCTCATATACTGACCAA 710
MP5 11168_00278 AGCGTAACAGAAGCTAGGCTTGATTAT GCCATTATTGACATTGACTACTTGGACT 117
11168_00719 CCTTATAGAGATGTTGCAGAGGCTATCG CCTTGAACTCTTTGTCCACTTCCATTTG 506
11168_01072 GGGGTGGATTGTCATTAATTTACTAACC ACAGAAGAAACTGATACTTGCAAACTCC 276
11168_01610 ACTACAAGAAGCCAATCAACACCATG AAATTATCATCCACTCCCATACGCATCA 183
MP6 11168_00052 TGAAGTTATAGCCTTTGCCAAACCTGAT CGCACATTCCACCAAATCGAACAAG 119
11168_00280 GAAAGCCACGCAAATGGGGTAAAAG CCTGAACCTATGCCGATTGTTGGAA 302
07_0675_00227 ACAATGACGATATGGAACAGTGGGATG CAGATTGACCTTCAGGCGTTGATGA 240
MP1-F 11168_00051 AGGTGCTTTGCCTTATCGTGGAAAA ACCCATAGCCATTTCGTATTCTTTCACA 400
11168_00248 TCCTTTACAGCACTATACCGCCGATA TCCACTTGATTTCCAGCCATAACTTCC 241
11168_00278 AGCGTAACAGAAGCTAGGCTTGATTAT GCCATTATTGACATTGACTACTTGGACT 117
11168_01072 GGGGTGGATTGTCATTAATTTACTAACC ACAGAAGAAACTGATACTTGCAAACTCC 276
11168_01519 CTTACGAGAGATTAAACGCCTTGAAAGC ACGCCCTAGTTCTTGGTATAATGCTAAG 356
11168_01610 ACTACAAGAAGCCAATCAACACCATG AAATTATCATCCACTCCCATACGCATCA 183
MP2-F 11168_00244 TTGGACGCTTGATTCTTGATGCAATT ACTGACTATCAATGACAATAAACCAGCT 119
11168_00277 GCAGAAATTGCTTGATTTGCTTTTTACT TTTTGTCCCTCTTTGATAACCTTGTTTT 198
11168_00718 AACCCACACAAACTATACAAGAGCCTTC AAGAACCTCCCCACTCATACGCATT 314
11168_01309 GGAACTTCTATGGCAGCACCTATGG TCCTTGCACGGTTAAATCATTCAAATCT 870
07_0675_00227 ACAATGACGATATGGAACAGTGGGATG CAGATTGACCTTCAGGCGTTGATGA 240
Primer Sequence (5' - 3')
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3.3.4 Validation
The optimised multiplex PCR assays were screened against a total of 362 C. jejuni
strains, which included a validation panel of 221 strains previously characterised by
whole genome sequencing. The dataset was composed of 188 isolates from 34 CGF
subtypes classified as UN/CA, and 174 isolates from 31 CGF subtypes classified as NCA.
The statistical significance of each marker (p < 0.05) was defined based on its carriage
rate in the UN/CA and NCA cohorts and computed u
GenomeFisher (https://bitbucket.org/peterk87/genomefisher/wiki/Home); p-values were
adjusted for multiple testing using the method of Holm (Aickin & Gensler, 1996;
Gaetano, 2013; Holm, 1979). The concordance between the in silico gene
presence/absence data from the original GWAS and experimental PCR data from the
sequenced strains, as well as the overall distribution of markers between the UN/CA and
NCA cohorts, were used to select a subset of robust markers to facilitate high throughput
screening. A total of 11 markers were reorganised into the finalised C. jejuni Risk
Assessment (CJRA) assay comprising two multiplex PCRs (MP1-F and MP2-F, Table
3.2), and optimised as described above. The final PCR mixtures consisted of 1 µL of
nucleic acid, 0.2 µL of Taq Polymerase, 3.0 mM MgCl2, 0.2 mM of each dNTP, 0.2 µM
of each primer in 10 x reaction buffer with PCR-grade water to a final volume of 25 µL.
The PCR cycling conditions were unchanged.
3.3.5 Deployment of the C. jejuni Risk Assessment (CJRA) Assay
An additional 591 C. jejuni
in broiler chicken (CFIA, 2016) were screened using the CJRA Assay. CGF subtyping
(Clark et al., 2012; Taboada et al., 2012) was subsequently carried out by the National
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to classify these strains
as NCA or UN/CA based on the percentage of clinical isolates present in their respective
CGF subtypes as described above.
3.3.6 Generation of a minimum spanning tree
A Minimum Spanning Tree (MST) was generated and visualised using PHYLOViZ
2.0 (Nascimento et al., 2017) based on all unique C. jejuni CGF subtypes (n=2,610)
characterised in the Canadian Campylobacter CGF Database (C3GFdb). Subtyping data
were input in a format compatible with the Multi-Locus Sequence Type (MLST) module
in PHYLOViZ, and the goeBURST Full MST algorithm was used to construct the tree.
A companion file based on all C. jejuni strains (n=17,279) characterised in the C3GFdb
was used to overlay strain metadata onto the MST to visualise features of the population
structure of C. jejuni in Canada.
3.4 Results and discussion
3.4.1 Validation of the putative diagnostic markers
Although the putative diagnostic markers were subjected to a rigorous in silico
validation that clearly demonstrated a biased distribution amongst strains from clinically
associated subtypes, a large majority of the publicly available C. jejuni genomes used in
the study were of human clinical origin, and there was a paucity of genomic data derived
from strains of subtypes rarely associated with human illness (Buchanan et al., 2017).
Therefore, in addition to assessing the concordance between the in silico and
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experimental PCR results, this validation was critical towards testing the markers against
additional strains from Non-Clinically-Associated subtypes.
Twenty-six of the 28 markers identified in the GWAS were organised into six
multiplex PCR assays. Two markers (Cj0259 and Cj0297c) were dropped due to poor
amplification results, however, since both were members of different linkage groups
comprising genes with similar carriage rates, their signal was considered redundant, and
their exclusion from the assay was deemed acceptable. The six multiplex PCR assays
were screened against a total of 362 C. jejuni strains including 188 strains from 34 CGF
subtypes classified as NCA (<5% human clinical). Among the validation dataset were
221 strains with whole genome sequence data. The overall concordance between the in
silico and experimental PCR results was 98.8% (5678/5746 matching loci), and the
number of discordant results for individual markers ranged from 0 to 13 discrepancies.
The statistical significance of each marker based on its distribution between both cohorts
was assessed, and all 26 markers exhibited statistically significant signal with clinically
associated subtypes, with p-values ranging from 2.8 x 10-2 to 7.3 x 10-63 (Table 3.3).
Overall, these results are similar to those reported in Buchanan et al., 2017, except three
markers (06_2866_00597, 06_7515_00723 and Cj1255), which were not statistically
associated with UN/CA subtypes in the in silico study, were found to be significant in this
validation. On average, the markers were present in 76% of strains from UN/CA
subtypes compared to only 26% of strains from NCA subtypes (Figure 3.1), while the
average number of markers present in strains from UN/CA subtypes was 20, and seven in
strains from NCA subtypes. Overall, the assay detected 100% of strains from UN/CA
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subtypes, and 65% of strains from NCA subtypes (a strain was considered to be detected
if at least one marker was present).
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Table 3.3: The statistical significance of each putative diagnostic marker after screening
against the validation dataset of C. jejuni strains.
Marker Raw Holm-corrected2
11168_00051 6.54E-30 9.16E-29
11168_00052 1.95E-29 2.53E-28
11168_00169 3.84E-04 1.54E-03
11168_00170 4.64E-08 3.68E-07
11168_00171 1.14E-04 5.69E-04
11168_00172 3.84E-04 1.54E-03
11168_00173 7.44E-05 4.46E-04
11168_00230 1.30E-09 1.17E-08
11168_00244 4.24E-62 1.02E-60
11168_00248 2.80E-64 7.27E-63
11168_00249 8.06E-56 1.77E-54
11168_00277 8.37E-62 1.93E-60
11168_00278 6.32E-55 1.33E-53
11168_00280 2.88E-53 5.46E-52
11168_00281 1.79E-62 4.48E-61
11168_00703 5.21E-14 5.21E-13
11168_00718 1.02E-48 1.84E-47
11168_00719 1.84E-35 2.76E-34
11168_01072 1.30E-53 2.60E-52
11168_01201 2.87E-02 2.87E-02
11168_01309 3.21E-47 5.46E-46
11168_01519 2.24E-19 2.47E-18
11168_01610 1.61E-44 2.58E-43
06_2866_00597 4.60E-08 3.68E-07
06_7515_00723 4.22E-04 1.54E-03
07_0675_00227 1.80E-26 2.16E-25
1 p-value based on 2-tailed Fisher's Exact Test
2 p-values were adjusted using the Holm-correction (Holm, 1979)
p-value1
06_2866_00597_710bp
06_7515_00723_803bp
07_0675_00227_240bp
11168_00051_400bp
11168_00052_119bp
11168_00169_373bp
11168_00170_623bp
11168_00171_305bp
11168_00172_101bp
11168_00173_282bp
11168_00230_205bp
11168_00244_119bp
11168_00248_241bp
11168_00249_166bp
11168_00277_198bp
11168_00278_117bp
11168_00280_302bp
11168_00281_209bp
11168_00703_275bp
11168_00718_314bp
11168_00719_506bp
11168_01072_276bp
11168_01201_139bp
11168_01309_870bp
11168_01519_356bp
11168_01610_183bp
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Of the 174 strains from NCA subtypes, no markers were present in 61 strains, while
various numbers of markers were observed in the remainder, which could be indicative of
some level of risk despite membership in CGF subtypes not presently associated with
human campylobacteriosis. A minimum spanning tree based on data from the C3GFdb
was used to examine NCA subtypes with positive markers to better contextualise their
underlying epidemiological properties based on the characteristics of related subtypes.
For example, strains from the NCA subtype 0170_003_002 were positive for all 26
markers, which would suggest an elevated risk for human pathogenesis. In fact, this
subtype is highly related to one of the most prevalent CA subtypes in Canada. Of the 24
NCA subtypes encompassing strains positive for one or more putative diagnostic marker,
14 were exclusive to, or predominantly carried by raccoons, which more recently, have
been shown to carry strains capable of causing disease in humans (Saunders et al., 2017).
Raccoons occupy a unique habitat at the interface of farm and/or urban environments,
which can bring them into close proximity with livestock, pets and people (Rainwater et
al., 2017). While investigation of similar subtypes did not yield many instances of strains
from human clinical cases, overlap with strains from poultry, cattle and environmental
waters was observed, which underscores a potentially underappreciated facet of
campylobacteriosis epidemiology involving wild animals, and their ability to transmit a
diverse range of C. jejuni lineages between the wild, farm and urban environments
(Whiley et al., 2013). Although these subtypes have not been previously associated with
human campylobacteriosis, it should be noted that this may not necessarily be a reflection
of pathogenicity, but a potential knowledge gap resulting from the incomplete
surveillance of C. jejuni including from human clinical cases (Figure 3.2).
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A subset of robust markers was selected for an abbreviated, more user-friendly
assay, which excluded any marker present in more than 20% of strains from NCA
subtypes, and included one or two markers representative of each linkage group. A total
of 11 markers were selected, which could still detect all strains from the UN/CA
subtypes. These markers were re-organised into two multiplex PCR assays and re-
optimised before implementation in the laboratory as the C. jejuni Risk Assessment
(CJRA) assay (Table 3.2).
3.4.2 Deployment of the C. jejuni Risk Assessment (CJRA) Assay
The is the first ever Canadian study examining
Campylobacter in broiler chicken, and thus, provided an attractive opportunity to further
assess the CJRA Assay for several reasons. C. jejuni is highly prevalent in raw poultry
meat and poultry by-products, accounting for a significant proportion (65-69%) of human
campylobacteriosis cases in Canada (Ravel et al., 2017; Suzuki & Yamamoto, 2009;
Williams & Oyarzabal, 2012), and the scope of this survey is unparalleled, targeting
poultry products at the farm, abattoir and retail sectors across Canada accounting for
92.9% of total chicken production and retail sampling designed to reflect the purchasing
habits of a majority of the Canadian population (i.e. 62%) (CFIA, 2016). To that end, an
additional 601 C. jejuni isolates were screened using the CJRA Assay, bringing the total
number of isolates tested to 963. The final dataset encompassed 581 C. jejuni strains
from 76 UN/CA subtypes and 382 strains from 112 NCA subtypes. Overall, the markers
were present, on average, in 68% of strains from UN/CA subtypes compared to only 24%
of strains from NCA subtypes (Figure 3.3), while the average number of markers present
in strains from UN/CA subtypes was eight, and three in strains from NCA subtypes.
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Overall, the assay detected 99.7% (579/581) of strains from UN/CA subtypes, and 65%
(247/382) of strains from NCA subtypes. Amongst the strains from the MBS, the
markers were present, on average, in 65% of strains from UN/CA subtypes, and 37% of
strains from NCA subtypes, while the average numbers of markers present in strains from
UN/CA subtypes was seven, and four in strains from NCA subtypes. The assay detected
99.5% (389/391) of strains from the UN/CA subtypes, and 90.0% (180/200) of strains
from NCA subtypes.
07_0675_00227_240bp
11168_00051_400bp
11168_00244_119bp
11168_00248_241bp
11168_00277_198bp
11168_00278_117bp
11168_00718_314bp
11168_01072_276bp
11168_01309_870bp
11168_01519_356bp
11168_01610_183bp
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The National Microbiology Campylobacter Genomics Laboratory
completed CGF subtyping on all C. jejuni isolates collected during the MBS, including
those assessed in this study using the CJRA Assay. In total, 352 subtypes were
characterised in the survey, and C. jejuni strains from 166 of those subtypes, representing
85% (2,045/2,401) of the collection, were assessed with the CJRA Assay. Despite the
breadth of the C3GFdb, which includes more than 26,000 Campylobacter strains
representing over 4,800 unique subtypes, over a third of the subtypes characterised in the
MBS were novel (n=137). This is a testament to the ability of C. jejuni to generate
genetic diversity, and a stark reminder of the complexity of its population structure.
Overall, we observed a relationship suggesting an increasing proportion of clinical
isolates in CGF subtypes and the number of positive CJRA markers in strains they
include, which could eventually be used to develop a risk prediction scheme (i.e. low,
medium, high risk) for a strain based on the number of markers present. However, there
were a number of strains from CGF subtypes classified as NCA that were positive for at
least one CJRA marker (Figure 3.4). For example, among the MBS isolates tested with
the CJRA Assay, 37 strains were from 31 novel CGF subtypes classified as NCA based
on the absence of any clinical association; more than half of these were positive for five
or more CJRA markers suggesting a greater level of risk than the NCA classification
would imply. Novel subtypes, in addition to rare subtypes, or those biased by
oversampling are problematic because they lack robust epidemiological signal to
confidently infer pathogenic risk. This problem is further exacerbated by underreporting
at the clinical level, or the lack of clinical surveillance (Allos & Blaser, 1995), which
limits our ability to project these important metadata over the population structure of C.
jejuni. In fact, this is a possible explanation for the higher than expected detection of
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high-risk strains from subtypes classified as NCA in the MBS. Additionally, we observed
that strains with identical CGF subtypes also shared an identical or similar distribution of
risk markers (Figure 3.5). Although more validation is required, these data suggest that it
might be possible to assign risk to the subtype itself, similar to how other human
pathogens are classified (e.g. the seropathotyping scheme for shigatoxigenic E. coli
(Karmali et al., 2003)). This would allow the CJRA Assay to be used to assign risk to
emerging and poorly-defined subtypes in the absence of other metadata used to predict
pathogenic risk, and allow public health officials to expedite a response when a high-risk
strain is detected.
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Figure 3.5: Strains screened using the finalised CJRA Assay were clustered based on
their CGF subtype. Strains from subtypes classified as NCA are coloured green, and
those classified as CA are coloured blue. The number of CJRA markers present were
binned (i.e. 0-2, 3-5, 6-8, 9-11) and colour-coded from light orange to dark red. The
binarised CJRA Assay risk profile was added for each strain. As was observed in Figure
4, there is a possible correlation between the risk classification (i.e. NCA and CA) and the
number of CJRA markers present, which could eventually be used to develop a risk
prediction scheme (i.e. low, medium, and high-risk) based on the number of markers
present. Strains with identical CGF subtypes generally possessed an identical or similar
distribution of risk markers. Although further validation is required, these data suggest it
might be possible to assign a risk level to the subtype itself, similar to how other human
pathogens are classified (e.g. the seropathotyping scheme for shigatoxigenic E. coli
(Karmali et al., 2003)).
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3.5 Conclusion
C. jejuni on farm (average prevalence of 24.1%), at slaughter (average prevalence of
33%) and at retail (average prevalence of 41.8%) (CFIA, 2016). Subsequent
characterisation of isolates using CGF revealed a wide variety of lineages circulating
within poultry flocks, including a large number of novel subtypes where the pathogenic
potential could not be established based on the current understanding of the population
structure of C. jejuni and a paucity of human surveillance data in Canada. Based on the
in silico validation described in Chapter 2 (Buchanan et al., 2017), and the expanded
validation described here, the putative diagnostic markers identified in the GWAS are
demonstrably associated with clinically associated CGF subtypes. Therefore, it is
reasonable to assume that the detection of high-risk strains amongst subtypes classified as
NCA in the MBS is legitimate and demonstrates the utility of the CJRA Assay to infer
risk in cases where the underlying epidemiological data is lacking. It is possible the
CJRA Assay could enhance the current framework used to study the epidemiology of
campylobacteriosis retrospectively by assessing strains from known subtypes that lack
robust epidemiological signal, and proactively by assessing strains from novel and
emerging subtypes. This would enable public health officials to better identify and track
high-risk C. jejuni strains circulating within the environment and food chain, and
prioritise cases based on risk level as is done with other bacterial pathogens. These data
can also be used to help implement targeted mitigation strategies to limit human exposure
to C. jejuni.
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Chapter 4
4 Conclusions and future directions
4.1 Conclusions
Despite the fact that C. jejuni is a leading cause of bacterial enteritis in Canada and
abroad, there is currently no diagnostic assay available to identify strains that present an
elevated risk for human health (Blaser, 1997; Thomas, M. et al., 2013). Molecular
epidemiological data suggest that not all C. jejuni subtypes pose an equal risk to human
health, however, it is unclear what drives this subtype-specific pathogenesis (Buchanan et
al., 2017; French et al., 2005; Sheppard et al., 2012). Therefore, the first component of
this thesis was to identify genetic markers associated with C. jejuni strains known to
cause disease in humans. This was accomplished by conducting a Genome-Wide
Association Study (GWAS) comparing the gene content between strains from prominent
non-pathogenic and pathogenic CGF subtypes circulating in Canada. The analysis
yielded 28 putative markers that were statistically significantly linked to C. jejuni strains
from subtypes associated with human illness, which included genes involved in iron
acquisition and vitamin B5 biosynthesis, in addition to those encoding putative proteins
associated with catalysis and transport. Some of the genes identified have been shown
experimentally to be important for colonisation, survivability and host transmissibility
(Naikare et al., 2013; Palyada et al., 2004; Sheppard et al., 2013), while the role in C.
jejuni pathogenesis (if any) of the other markers is as of yet undefined. Broadly, these
data suggest that the hallmark of high-risk strains might be their ability to overcome
ecological barriers enroute to the human host, namely, the ability to withstand adverse
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environmental conditions, and the ability to efficiently transition between hosts (Dearlove
et al., 2016; Gripp et al., 2011; Oh et al., 2018). The markers were subjected to an in
silico validation using a much larger and epidemiologically diverse dataset comprising all
available WGS data that possessed sufficient epidemiological metadata to determine a
diagnostic behaviour for the identification of pathogenic C. jejuni strains.
The second component of this thesis was to develop a PCR-based diagnostic assay
using the genetic markers identified in the GWAS. Primers for all 28 markers were
designed, of which 26 were implemented into six multiplex PCR assays and screened
against a panel of C. jejuni strains from both non-clinically and clinically-associated
lineages. Although, all markers exhibited robust diagnostic behaviour for detection of
pathogenic C. jejuni strains, a subset comprising the best-performing markers was re-
organised into two multiplex PCR assays to facilitate higher throughput and faster
turnaround time. The finalised Campylobacter jejuni Risk Assessment (CJRA) Assay
comprising two multiplex PCR assays representing 11 markers, was deployed against a
pan-Canadian set of C. jejuni
Study in broiler chicken (CFIA, 2016). In combination with CGF subtyping, the analysis
revealed several salient features: 1) C. jejuni is highly prevalent in Canadian chickens and
poultry products; 2) there are many novel subtypes circulating in the Canadian poultry
chain comprising strains that possess an elevated risk for human illness; 3) the CJRA
Assay was able to identify potentially high-risk strains from novel subtypes in the
absence of other epidemiological data; 4) when strains are clustered based on CGF
subtype, identical strains also share an identical or similar distribution of risk markers;
and 5) there was a positive trend between the number of positive markers and the
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proportion of human clinical isolates within a CGF subtype. Therefore, not only will the
CJRA Assay be useful for identifying high-risk C. jejuni strains, but with further
the seropathotyping scheme devised for shigatoxigenic E. coli. In the seropathotyping
scheme, serotypes are ranked for risk based on their occurrence in human disease,
severity of disease and association with outbreaks (Karmali et al., 2003). Such a model
for C. jejuni would allow public health officials to make more informed decisions on how
to deploy resources to mitigate campylobacteriosis in Canada.
4.2 Future directions
4.2.1 Are all C. jejuni pathogenic?
C. jejuni is unique amongst human bacterial enteric pathogens as it does not possess
many classical virulence factors, and those it does have, are broadly conserved across the
species (Dorrell et al., 2001). A possible implication of this is that all C. jejuni are
inherently pathogenic in a naïve human host. However, molecular epidemiological data,
including MLST and CGF, have shown that not all lineages are equally implicated in
disease in humans (Buchanan et al., 2017; French et al., 2005; Sheppard et al., 2012).
The GWAS conducted in this work revealed a number of genetic markers that were
statistically associated with strains from subtypes known to cause disease in humans.
Amongst these markers were genes encoding multiple iron acquisition systems, which
have been well-studied in C. jejuni and shown to be important for colonisation in model
animals, and may play role in survivability and host transmission (Naikare et al., 2013;
Palyada et al., 2004; Zeng et al., 2013). Additionally, genes encoding the vitamin B5
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biosynthesis pathway were identified in this study, which more recently, have been shown
to be important for rapid transmission between hosts (Sheppard et al., 2013). While the
analysis revealed a number of other genes related to transport and catabolism, in addition
to those with no known function, their roles, if any, in the pathogenesis of C. jejuni
remain undefined, and represent an avenue for future research. Overall, these results
suggest the pathogenicity of C. jejuni may not be linked to some as of yet identified
molecular machinery, but rather, to its ability to overcome ecological barriers or
bottlenecks enroute to the human host, and thus, the best markers for high-risk C. jejuni
might be genes that enhance its ecological robustness.
As stated above, while some of the markers represent well-studied genes in C.
jejuni, the analysis identified other genes encoding proteins with roles that are less well
defined, and represent an unknown quantity in terms of their role in C. jejuni
pathogenesis. Thus, future work could involve elucidating the functions of the proteins to
determine if and how they might enhance C. jejuni pathogenicity. CRISPR/Cas9
technology has greatly simplified our ability to precis
Therefore, this system can be used to generate knockout mutants for each gene to assess
subsequent effects on the phenotype. Broad-spectrum phenotypic arrays that assess
bacterial metabolism and chemical sensitivities can be used to rapidly compare the mutant
and wildtype strains, which may shed light on the function of the deleted protein.
Although the use of animal models to study C. jejuni has been restricted largely due to its
inability to cause disease in most common research animals, recent work has established
several mouse models that develop acute enterocolitis in response to C. jejuni. These
models could provide an avenue to evaluate the potential role of these genes in the
colonisation and infection by C. jejuni in vivo (Stahl et al., 2017).
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4.2.2 Increasing the resolution: whole genome SNP analysis
When the study was conceptualised, an early decision was made to conduct the
GWAS at the gene level for two reasons: 1) the hypothesis was based on the premise that
differences in pathogenicity would be linked to genes from the accessory genome; and 2)
to facilitate downstream implementation of a presence/absence PCR-based diagnostic
assay. Thus, by design, only the accessory gene content was interrogated. Therefore,
future work could be centred upon repeating the GWAS at the nucleotide level, which
would have the added advantage of interrogating the whole genome including both the
core and accessory gene content, as well as non-coding and regulatory regions of the
genome. Furthermore, with the imminent integration of whole genome sequencing in
routine diagnostics, important SNPs and other polymorphisms can be easily detected
using bioinformatic tools, making their use as diagnostic markers more palatable. GWAS
have been used to identify SNPs and other mutations associated with antibiotic resistance
in Mycobacterium tuberculosis (Farhat et al., 2013), Staphylococcus aureus (Alam et al.,
2014) and Streptococcus pneumoniae (Chewapreecha et al., 2014), as well as a recent
study investigating variant alleles in C. jejuni and C. coli associated with survival during
poultry processing (Yahara et al., 2017).
4.2.3 Developing a risk framework for C. jejuni
In general, strains that were identical by CGF, also shared an identical or similar
distribution of risk markers. Therefore, if risk profiles are found to be stable within a
CGF subtype, the risk of any given strain could be inferred based on its subtype so long
as that subtype has been previously characterised. This would negate having to run the
risk assessment assay, resulting in an expedited risk analysis.
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While the markers identified in this study have not, as of yet, been linked to
virulence, if the appropriate metadata comes available, it could be beneficial to determine
if the presence of certain markers can be correlated to certain epidemiological features
(e.g. associated with outbreaks), or more severe disease outcomes (e.g. diarrhea,
hospitalisation, etc.). Additionally, we observed a trend where strains with more risk
markers came from CGF subtypes comprising a higher proportion of human clinical
strains. These features could be used to develop a risk framework for C. jejuni whereby a
classification
its CGF subtype, the presence of certain markers and the number of markers present. An
analogous system exists for shigatoxigenic E. coli, where serotypes are grouped into
-E) based on their epidemiological
characteristics including their occurrence in human disease, the severity of disease, and
whether they are associated with outbreaks (Karmali et al., 2003).
In order to develop such a framework for C. jejuni, further validation is required.
More strains from well-characterised NCA and CA CGF subtypes need to be screened to
ensure 1) that the markers continue to show a biased distribution amongst strains
associated with human disease, 2) that the intra-subtype distribution of risk markers is
stable, and thus, a reliable proxy for risk for a given subtype, and 3) whether risk can be
inferred from one subtype to a similar one. However, it is important to note that a
significant roadblock to implementing such a framework for C. jejuni in Canada is the
paucity of human surveillance data. These data are necessary for determining which
subtypes are causing disease in humans, how frequently and to what extent (i.e. severity
of disease, manifestation of post-infection sequelae), and are needed in combination with
data from the CJRA Assay to help inform the development of classifications
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similar to the seropathotypes for shigatoxigenic E. coli. In the absence of domestic
data, a possible work around is to leverage publicly-available WGS data from partner
countries for further validation of the CJRA Assay and to help develop a risk framework
for C. jejuni.
4.2.4 Towards implementation of the CJRA Assay: the poultry production
continuum as a model
crobial Baseline Survey, C. jejuni was isolated at all
stages of the poultry production continuum including the farm, abattoir and retail levels
(CFIA, 2016). In this study, CGF subtyping in conjunction with the C. jejuni Risk
Assessment Assay demonstrated that there is a wide variety of lineages circulating within
Canadian poultry flocks, including many comprising strains that pose an elevated risk to
human health. Because poultry is considered to be the most important route of infection
for C. jejuni, intervention at key points of the poultry production chain could be the most
effective strategy for mitigating human campylobacteriosis in Canada. As such, the
poultry production chain can be used as a framework for the implementation of an
enhanced molecular-based surveillance system that is capable of characterising which
subtypes are in circulation along with their associated risk at each stage of production.
These data can be used to develop targeted mitigation strategies designed to minimise
both human campylobacteriosis, as well as food waste.
Implementation of on-farm sampling could be used to identify potential sources of
contamination leading to flock infection, which could be used to inform the
implementation of farm-specific and potentially industry-wide intervention strategies.
Additionally, on-farm testing can be used to develop a gating system where chicken
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carrying high-risk strains are diverted from general processing at centrally-located
abattoirs minimising the potential for cross-contamination during slaughter and
processing. Chicken flagged as carrying high-risk strains could then be processed
separately and used for specialised products (i.e. cooked and frozen chicken nuggets),
which should eliminate the bacterium, and reduce the risk of campylobacteriosis.
Sampling at the abattoir along each stage of the slaughtering process could be used to
determine if and where contamination is occurring; these data could be used to inform the
implementation of new intervention strategies, and determine whether currently-used
intervention strategies are efficacious. Testing products prior to their shipment to retail
outlets could provide a final gating measure to prevent products contaminated with high-
risk strains from being sold.
Recognising that this strategy would be costly to implement, and therefore, unlikely
to garner support from industry partners and diagnostic laboratories over the long-term,
the above strategy might be best implemented as a pilot study used to inform the
development of a more sustainable, culture-free assay where raw samples (e.g. faeces,
tissues, rinses, etc.) are tested directly. The pilot study would therefore be critical for
determining which risk marker(s) are the most diagnostic for human pathogenic C. jejuni,
as well as which points along the poultry production chain should be tested.
Technologies such as real-time PCR and loop-mediated isothermal amplification are
sensitive, and both rapid and inexpensive compared to isolation and subsequent
downstream characterisation (i.e. subtyping and risk assessment) of C. jejuni. However,
there are several limitations that need to be considered: 1) since both real-time PCR and
loop-mediated isothermal amplification are less-amenable to multiplexing, it is necessary
to determine which risk markers represent the best candidates to carry forward; 2) raw
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samples will comprise nucleic acids from any number of microorganisms including the
host, and therefore a suitable species-specific marker gene unique to C. jejuni would need
to be incorporated into the assay to bolster a positive result; 3) the culture-free assay
would need to be validated against current isolation/characterisation techniques to ensure
that a positive result (i.e. detection of the species-specific C. jejuni marker and risk
marker(s)) is due to the presence of C. jejuni with the selected risk marker, and not a
result of non-specific amplification, cross-reactivity, or the combination of signal from
multiple microorganisms.
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